Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MXI1
|
ENSG00000119950.16 | MAX interactor 1, dimerization protein |
MYC
|
ENSG00000136997.10 | MYC proto-oncogene, bHLH transcription factor |
MYCN
|
ENSG00000134323.10 | MYCN proto-oncogene, bHLH transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MXI1 | hg19_v2_chr10_+_111967345_111967442 | -0.54 | 1.3e-03 | Click! |
MYC | hg19_v2_chr8_+_128747757_128747800 | 0.50 | 3.6e-03 | Click! |
MYCN | hg19_v2_chr2_+_16080659_16080686 | -0.42 | 1.8e-02 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr11_-_64014379 | 6.62 |
ENST00000309318.3
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr17_+_72428218 | 5.84 |
ENST00000392628.2
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr7_-_27169801 | 5.59 |
ENST00000511914.1
|
HOXA4
|
homeobox A4 |
chr6_+_31865552 | 5.47 |
ENST00000469372.1
ENST00000497706.1 |
C2
|
complement component 2 |
chr1_-_27240455 | 5.15 |
ENST00000254227.3
|
NR0B2
|
nuclear receptor subfamily 0, group B, member 2 |
chr11_-_57282349 | 5.15 |
ENST00000528450.1
|
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
chr17_+_72428266 | 4.89 |
ENST00000582473.1
|
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr1_+_43148625 | 4.88 |
ENST00000436427.1
|
YBX1
|
Y box binding protein 1 |
chr3_+_184032419 | 4.82 |
ENST00000352767.3
ENST00000427141.2 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr7_-_27170352 | 4.61 |
ENST00000428284.2
ENST00000360046.5 |
HOXA4
|
homeobox A4 |
chr11_-_47470703 | 4.57 |
ENST00000298854.2
|
RAPSN
|
receptor-associated protein of the synapse |
chr8_+_17354617 | 4.21 |
ENST00000470360.1
|
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr11_-_47470591 | 4.19 |
ENST00000524487.1
|
RAPSN
|
receptor-associated protein of the synapse |
chr8_+_17354587 | 4.16 |
ENST00000494857.1
ENST00000522656.1 |
SLC7A2
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 |
chr14_-_24658053 | 4.16 |
ENST00000354464.6
|
IPO4
|
importin 4 |
chr3_-_50329835 | 4.15 |
ENST00000429673.2
|
IFRD2
|
interferon-related developmental regulator 2 |
chr2_-_10588630 | 4.15 |
ENST00000234111.4
|
ODC1
|
ornithine decarboxylase 1 |
chr11_-_116663127 | 4.13 |
ENST00000433069.1
ENST00000542499.1 |
APOA5
|
apolipoprotein A-V |
chr2_+_10183651 | 4.13 |
ENST00000305883.1
|
KLF11
|
Kruppel-like factor 11 |
chr17_+_72427477 | 4.08 |
ENST00000342648.5
ENST00000481232.1 |
GPRC5C
|
G protein-coupled receptor, family C, group 5, member C |
chr1_-_1850697 | 3.92 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
chr17_-_2614927 | 3.88 |
ENST00000435359.1
|
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
chr12_+_54378923 | 3.86 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr12_+_50497784 | 3.84 |
ENST00000548814.1
|
GPD1
|
glycerol-3-phosphate dehydrogenase 1 (soluble) |
chr17_+_1627834 | 3.82 |
ENST00000419248.1
ENST00000418841.1 |
WDR81
|
WD repeat domain 81 |
chr3_+_184032283 | 3.75 |
ENST00000346169.2
ENST00000414031.1 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chr12_+_81110684 | 3.75 |
ENST00000228644.3
|
MYF5
|
myogenic factor 5 |
chr2_-_20424844 | 3.70 |
ENST00000403076.1
ENST00000254351.4 |
SDC1
|
syndecan 1 |
chr7_-_27205136 | 3.66 |
ENST00000396345.1
ENST00000343483.6 |
HOXA9
|
homeobox A9 |
chr2_+_119981384 | 3.60 |
ENST00000393108.2
ENST00000354888.5 ENST00000450943.2 ENST00000393110.2 ENST00000393106.2 ENST00000409811.1 ENST00000393107.2 |
STEAP3
|
STEAP family member 3, metalloreductase |
chr12_-_58146128 | 3.59 |
ENST00000551800.1
ENST00000549606.1 ENST00000257904.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr12_-_58146048 | 3.55 |
ENST00000547281.1
ENST00000546489.1 ENST00000552388.1 ENST00000540325.1 ENST00000312990.6 |
CDK4
|
cyclin-dependent kinase 4 |
chr6_-_107436473 | 3.54 |
ENST00000369042.1
|
BEND3
|
BEN domain containing 3 |
chr12_-_49318715 | 3.53 |
ENST00000444214.2
|
FKBP11
|
FK506 binding protein 11, 19 kDa |
chrX_+_23685563 | 3.52 |
ENST00000379341.4
|
PRDX4
|
peroxiredoxin 4 |
chr11_-_47470682 | 3.49 |
ENST00000529341.1
ENST00000352508.3 |
RAPSN
|
receptor-associated protein of the synapse |
chr3_+_184032313 | 3.48 |
ENST00000392537.2
ENST00000444134.1 ENST00000450424.1 ENST00000421110.1 ENST00000382330.3 ENST00000426123.1 ENST00000350481.5 ENST00000455679.1 ENST00000440448.1 |
EIF4G1
|
eukaryotic translation initiation factor 4 gamma, 1 |
chrX_+_23685653 | 3.43 |
ENST00000379331.3
|
PRDX4
|
peroxiredoxin 4 |
chr20_+_61584398 | 3.41 |
ENST00000411611.1
|
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
chr11_+_120081475 | 3.41 |
ENST00000328965.4
|
OAF
|
OAF homolog (Drosophila) |
chr22_-_24181174 | 3.25 |
ENST00000318109.7
ENST00000406855.3 ENST00000404056.1 ENST00000476077.1 |
DERL3
|
derlin 3 |
chr17_-_2615031 | 3.21 |
ENST00000576885.1
ENST00000574426.2 |
CLUH
|
clustered mitochondria (cluA/CLU1) homolog |
chr1_+_44445549 | 3.20 |
ENST00000356836.6
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
chr12_+_71833756 | 3.14 |
ENST00000536515.1
ENST00000540815.2 |
LGR5
|
leucine-rich repeat containing G protein-coupled receptor 5 |
chr1_+_44445643 | 3.14 |
ENST00000309519.7
|
B4GALT2
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2 |
chr7_-_1595871 | 3.13 |
ENST00000319010.5
|
TMEM184A
|
transmembrane protein 184A |
chr11_-_126081532 | 3.11 |
ENST00000533628.1
ENST00000298317.4 ENST00000532674.1 |
RPUSD4
|
RNA pseudouridylate synthase domain containing 4 |
chr20_+_61584026 | 3.10 |
ENST00000370351.4
ENST00000370349.3 |
SLC17A9
|
solute carrier family 17 (vesicular nucleotide transporter), member 9 |
chr13_-_44735393 | 3.09 |
ENST00000400419.1
|
SMIM2
|
small integral membrane protein 2 |
chr1_-_159684371 | 3.08 |
ENST00000255030.5
ENST00000437342.1 ENST00000368112.1 ENST00000368111.1 ENST00000368110.1 ENST00000343919.2 |
CRP
|
C-reactive protein, pentraxin-related |
chr3_+_186648507 | 3.05 |
ENST00000458216.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr3_-_183967296 | 3.04 |
ENST00000455059.1
ENST00000445626.2 |
ALG3
|
ALG3, alpha-1,3- mannosyltransferase |
chr12_+_3069037 | 2.96 |
ENST00000397122.2
|
TEAD4
|
TEA domain family member 4 |
chr17_-_40540586 | 2.93 |
ENST00000264657.5
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr5_-_140998616 | 2.91 |
ENST00000389054.3
ENST00000398562.2 ENST00000389057.5 ENST00000398566.3 ENST00000398557.4 ENST00000253811.6 |
DIAPH1
|
diaphanous-related formin 1 |
chr19_-_41903161 | 2.86 |
ENST00000602129.1
ENST00000593771.1 ENST00000596905.1 ENST00000221233.4 |
EXOSC5
|
exosome component 5 |
chr17_+_7211656 | 2.85 |
ENST00000416016.2
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr13_+_27998681 | 2.80 |
ENST00000381140.4
|
GTF3A
|
general transcription factor IIIA |
chr11_-_116662593 | 2.78 |
ENST00000227665.4
|
APOA5
|
apolipoprotein A-V |
chr17_+_62223320 | 2.76 |
ENST00000580828.1
ENST00000582965.1 |
SNORA76
|
small nucleolar RNA, H/ACA box 76 |
chr2_-_220083692 | 2.76 |
ENST00000265316.3
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr19_+_1275917 | 2.71 |
ENST00000469144.1
|
C19orf24
|
chromosome 19 open reading frame 24 |
chr5_-_140998481 | 2.70 |
ENST00000518047.1
|
DIAPH1
|
diaphanous-related formin 1 |
chr2_-_220083671 | 2.70 |
ENST00000439002.2
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr2_+_234959323 | 2.69 |
ENST00000373368.1
ENST00000168148.3 |
SPP2
|
secreted phosphoprotein 2, 24kDa |
chr9_-_35691017 | 2.68 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr6_-_31763408 | 2.67 |
ENST00000444930.2
|
VARS
|
valyl-tRNA synthetase |
chr12_+_57623869 | 2.67 |
ENST00000414700.3
ENST00000557703.1 |
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr17_+_49230897 | 2.67 |
ENST00000393196.3
ENST00000336097.3 ENST00000480143.1 ENST00000511355.1 ENST00000013034.3 ENST00000393198.3 ENST00000608447.1 ENST00000393193.2 ENST00000376392.6 ENST00000555572.1 |
NME1
NME1-NME2
NME2
|
NME/NM23 nucleoside diphosphate kinase 1 NME1-NME2 readthrough NME/NM23 nucleoside diphosphate kinase 2 |
chr17_+_7211280 | 2.66 |
ENST00000419711.2
ENST00000571955.1 ENST00000573714.1 |
EIF5A
|
eukaryotic translation initiation factor 5A |
chr7_-_1595756 | 2.66 |
ENST00000441933.1
|
TMEM184A
|
transmembrane protein 184A |
chr8_+_22224760 | 2.61 |
ENST00000359741.5
ENST00000520644.1 ENST00000240095.6 |
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr12_+_57624119 | 2.61 |
ENST00000555773.1
ENST00000554975.1 ENST00000449049.3 ENST00000393827.4 |
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr3_+_52719936 | 2.59 |
ENST00000418458.1
ENST00000394799.2 |
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar) |
chr1_+_26496362 | 2.58 |
ENST00000374266.5
ENST00000270812.5 |
ZNF593
|
zinc finger protein 593 |
chr11_-_57283159 | 2.58 |
ENST00000533263.1
ENST00000278426.3 |
SLC43A1
|
solute carrier family 43 (amino acid system L transporter), member 1 |
chr3_+_52720187 | 2.56 |
ENST00000474423.1
|
GNL3
|
guanine nucleotide binding protein-like 3 (nucleolar) |
chr11_-_18343669 | 2.56 |
ENST00000396253.3
ENST00000349215.3 ENST00000438420.2 |
HPS5
|
Hermansky-Pudlak syndrome 5 |
chr11_+_17741111 | 2.55 |
ENST00000250003.3
|
MYOD1
|
myogenic differentiation 1 |
chr4_+_111397216 | 2.55 |
ENST00000265162.5
|
ENPEP
|
glutamyl aminopeptidase (aminopeptidase A) |
chr4_-_100242549 | 2.55 |
ENST00000305046.8
ENST00000394887.3 |
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide |
chr12_+_57624085 | 2.55 |
ENST00000553474.1
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr12_+_57623477 | 2.54 |
ENST00000557487.1
ENST00000555634.1 ENST00000556689.1 |
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr6_-_31763276 | 2.54 |
ENST00000440048.1
|
VARS
|
valyl-tRNA synthetase |
chr17_-_34313685 | 2.53 |
ENST00000435911.2
ENST00000586216.1 ENST00000394509.4 |
CCL14
|
chemokine (C-C motif) ligand 14 |
chr1_-_159915386 | 2.52 |
ENST00000361509.3
ENST00000368094.1 |
IGSF9
|
immunoglobulin superfamily, member 9 |
chr12_+_54348618 | 2.47 |
ENST00000243103.3
|
HOXC12
|
homeobox C12 |
chr12_+_54519842 | 2.44 |
ENST00000508564.1
|
RP11-834C11.4
|
RP11-834C11.4 |
chr12_+_57623907 | 2.44 |
ENST00000553529.1
ENST00000554310.1 |
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr3_+_186649133 | 2.44 |
ENST00000417392.1
|
ST6GAL1
|
ST6 beta-galactosamide alpha-2,6-sialyltranferase 1 |
chr2_-_198364581 | 2.42 |
ENST00000428204.1
|
HSPD1
|
heat shock 60kDa protein 1 (chaperonin) |
chr1_+_230203010 | 2.41 |
ENST00000541865.1
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr1_-_11120057 | 2.38 |
ENST00000376957.2
|
SRM
|
spermidine synthase |
chr19_-_33793430 | 2.37 |
ENST00000498907.2
|
CEBPA
|
CCAAT/enhancer binding protein (C/EBP), alpha |
chr11_-_64013663 | 2.36 |
ENST00000392210.2
|
PPP1R14B
|
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
chr12_-_58145889 | 2.36 |
ENST00000547853.1
|
CDK4
|
cyclin-dependent kinase 4 |
chr16_+_72042487 | 2.35 |
ENST00000572887.1
ENST00000219240.4 ENST00000574309.1 ENST00000576145.1 |
DHODH
|
dihydroorotate dehydrogenase (quinone) |
chr8_-_103668114 | 2.33 |
ENST00000285407.6
|
KLF10
|
Kruppel-like factor 10 |
chr8_-_9008206 | 2.31 |
ENST00000310455.3
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr7_+_116312411 | 2.31 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr10_-_95360983 | 2.30 |
ENST00000371464.3
|
RBP4
|
retinol binding protein 4, plasma |
chr5_-_37839782 | 2.30 |
ENST00000326524.2
ENST00000515058.1 |
GDNF
|
glial cell derived neurotrophic factor |
chr9_-_19127474 | 2.30 |
ENST00000380465.3
ENST00000380464.3 ENST00000411567.1 ENST00000276914.2 |
PLIN2
|
perilipin 2 |
chr1_+_110009215 | 2.28 |
ENST00000369872.3
|
SYPL2
|
synaptophysin-like 2 |
chr1_-_155145721 | 2.28 |
ENST00000295682.4
|
KRTCAP2
|
keratinocyte associated protein 2 |
chr12_-_6677422 | 2.27 |
ENST00000382421.3
ENST00000545200.1 ENST00000399466.2 ENST00000536124.1 ENST00000540228.1 ENST00000542867.1 ENST00000545492.1 ENST00000322166.5 ENST00000545915.1 |
NOP2
|
NOP2 nucleolar protein |
chr2_-_85829811 | 2.27 |
ENST00000306353.3
|
TMEM150A
|
transmembrane protein 150A |
chr19_+_50433476 | 2.25 |
ENST00000596658.1
|
ATF5
|
activating transcription factor 5 |
chr3_+_133292851 | 2.25 |
ENST00000503932.1
|
CDV3
|
CDV3 homolog (mouse) |
chr12_+_57624059 | 2.24 |
ENST00000557427.1
|
SHMT2
|
serine hydroxymethyltransferase 2 (mitochondrial) |
chr3_-_127541679 | 2.23 |
ENST00000265052.5
|
MGLL
|
monoglyceride lipase |
chr5_-_172198190 | 2.21 |
ENST00000239223.3
|
DUSP1
|
dual specificity phosphatase 1 |
chrX_+_118108601 | 2.20 |
ENST00000371628.3
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr8_+_22225041 | 2.19 |
ENST00000289952.5
ENST00000524285.1 |
SLC39A14
|
solute carrier family 39 (zinc transporter), member 14 |
chr12_-_58165870 | 2.19 |
ENST00000257848.7
|
METTL1
|
methyltransferase like 1 |
chr12_+_3068957 | 2.19 |
ENST00000543035.1
|
TEAD4
|
TEA domain family member 4 |
chr2_-_85829780 | 2.19 |
ENST00000334462.5
|
TMEM150A
|
transmembrane protein 150A |
chr3_+_133292759 | 2.18 |
ENST00000431519.2
|
CDV3
|
CDV3 homolog (mouse) |
chrX_+_118108571 | 2.18 |
ENST00000304778.7
|
LONRF3
|
LON peptidase N-terminal domain and ring finger 3 |
chr11_-_66725837 | 2.17 |
ENST00000393958.2
ENST00000393960.1 ENST00000524491.1 ENST00000355677.3 |
PC
|
pyruvate carboxylase |
chr8_+_67341239 | 2.17 |
ENST00000320270.2
|
RRS1
|
RRS1 ribosome biogenesis regulator homolog (S. cerevisiae) |
chr21_+_45209394 | 2.17 |
ENST00000497547.1
|
RRP1
|
ribosomal RNA processing 1 |
chr18_+_11981014 | 2.17 |
ENST00000589238.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr4_+_76649753 | 2.17 |
ENST00000603759.1
|
USO1
|
USO1 vesicle transport factor |
chr12_+_122516626 | 2.16 |
ENST00000319080.7
|
MLXIP
|
MLX interacting protein |
chr11_+_33037401 | 2.15 |
ENST00000241051.3
|
DEPDC7
|
DEP domain containing 7 |
chr3_-_142607740 | 2.12 |
ENST00000485766.1
|
PCOLCE2
|
procollagen C-endopeptidase enhancer 2 |
chr1_+_230202936 | 2.12 |
ENST00000366672.4
|
GALNT2
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2) |
chr15_+_50474412 | 2.11 |
ENST00000380902.4
|
SLC27A2
|
solute carrier family 27 (fatty acid transporter), member 2 |
chr17_-_40540377 | 2.11 |
ENST00000404395.3
ENST00000389272.3 ENST00000585517.1 ENST00000588065.1 |
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr6_-_31763721 | 2.10 |
ENST00000375663.3
|
VARS
|
valyl-tRNA synthetase |
chr11_-_63933504 | 2.09 |
ENST00000255681.6
|
MACROD1
|
MACRO domain containing 1 |
chr15_+_89164520 | 2.09 |
ENST00000332810.3
|
AEN
|
apoptosis enhancing nuclease |
chr17_-_40540484 | 2.08 |
ENST00000588969.1
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor) |
chr19_+_5681153 | 2.07 |
ENST00000579559.1
ENST00000577222.1 |
HSD11B1L
RPL36
|
hydroxysteroid (11-beta) dehydrogenase 1-like ribosomal protein L36 |
chr9_+_133320301 | 2.06 |
ENST00000352480.5
|
ASS1
|
argininosuccinate synthase 1 |
chr6_+_41888926 | 2.06 |
ENST00000230340.4
|
BYSL
|
bystin-like |
chr1_-_111991850 | 2.05 |
ENST00000411751.2
|
WDR77
|
WD repeat domain 77 |
chr10_-_6019552 | 2.04 |
ENST00000379977.3
ENST00000397251.3 ENST00000397248.2 |
IL15RA
|
interleukin 15 receptor, alpha |
chr8_+_98656336 | 2.04 |
ENST00000336273.3
|
MTDH
|
metadherin |
chr11_+_18287721 | 2.03 |
ENST00000356524.4
|
SAA1
|
serum amyloid A1 |
chr12_+_54393880 | 2.02 |
ENST00000303450.4
|
HOXC9
|
homeobox C9 |
chr9_+_4490394 | 2.02 |
ENST00000262352.3
|
SLC1A1
|
solute carrier family 1 (neuronal/epithelial high affinity glutamate transporter, system Xag), member 1 |
chr9_-_110251836 | 2.02 |
ENST00000374672.4
|
KLF4
|
Kruppel-like factor 4 (gut) |
chr21_+_38071430 | 2.02 |
ENST00000290399.6
|
SIM2
|
single-minded family bHLH transcription factor 2 |
chr8_-_144442136 | 2.01 |
ENST00000519148.1
|
TOP1MT
|
topoisomerase (DNA) I, mitochondrial |
chr3_-_50329990 | 2.01 |
ENST00000417626.2
|
IFRD2
|
interferon-related developmental regulator 2 |
chr3_+_183967409 | 2.00 |
ENST00000324557.4
ENST00000402825.3 |
ECE2
|
endothelin converting enzyme 2 |
chr2_+_111878483 | 2.00 |
ENST00000308659.8
ENST00000357757.2 ENST00000393253.2 ENST00000337565.5 ENST00000393256.3 |
BCL2L11
|
BCL2-like 11 (apoptosis facilitator) |
chr10_+_6244829 | 2.00 |
ENST00000317350.4
ENST00000379785.1 ENST00000379782.3 ENST00000360521.2 ENST00000379775.4 |
PFKFB3
|
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
chr7_-_150780609 | 1.99 |
ENST00000297533.4
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr19_+_10765699 | 1.99 |
ENST00000590009.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
chr3_+_122785895 | 1.98 |
ENST00000316218.7
|
PDIA5
|
protein disulfide isomerase family A, member 5 |
chr8_+_49984894 | 1.97 |
ENST00000522267.1
ENST00000399653.4 ENST00000303202.8 |
C8orf22
|
chromosome 8 open reading frame 22 |
chr12_-_103310987 | 1.97 |
ENST00000307000.2
|
PAH
|
phenylalanine hydroxylase |
chr10_-_82049424 | 1.97 |
ENST00000372213.3
|
MAT1A
|
methionine adenosyltransferase I, alpha |
chr14_+_24584508 | 1.96 |
ENST00000559354.1
ENST00000560459.1 ENST00000559593.1 ENST00000396941.4 ENST00000396936.1 |
DCAF11
|
DDB1 and CUL4 associated factor 11 |
chr8_-_9009079 | 1.96 |
ENST00000519699.1
|
PPP1R3B
|
protein phosphatase 1, regulatory subunit 3B |
chr3_-_127542051 | 1.96 |
ENST00000398104.1
|
MGLL
|
monoglyceride lipase |
chr2_+_131100710 | 1.96 |
ENST00000452955.1
|
IMP4
|
IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
chr10_-_76995769 | 1.95 |
ENST00000372538.3
|
COMTD1
|
catechol-O-methyltransferase domain containing 1 |
chr3_+_52017454 | 1.94 |
ENST00000476854.1
ENST00000476351.1 ENST00000494103.1 ENST00000404366.2 ENST00000469863.1 |
ACY1
|
aminoacylase 1 |
chr17_-_66453562 | 1.94 |
ENST00000262139.5
ENST00000546360.1 |
WIPI1
|
WD repeat domain, phosphoinositide interacting 1 |
chr15_+_96875657 | 1.94 |
ENST00000559679.1
ENST00000394171.2 |
NR2F2
|
nuclear receptor subfamily 2, group F, member 2 |
chr17_+_49243792 | 1.92 |
ENST00000393183.3
ENST00000393190.1 |
NME1-NME2
|
NME1-NME2 readthrough |
chr7_-_150780487 | 1.92 |
ENST00000482202.1
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr17_-_8059638 | 1.92 |
ENST00000584202.1
ENST00000354903.5 ENST00000577253.1 |
PER1
|
period circadian clock 1 |
chr12_-_64616019 | 1.91 |
ENST00000311915.8
ENST00000398055.3 ENST00000544871.1 |
C12orf66
|
chromosome 12 open reading frame 66 |
chr4_-_2758015 | 1.91 |
ENST00000510267.1
ENST00000503235.1 ENST00000315423.7 |
TNIP2
|
TNFAIP3 interacting protein 2 |
chr11_+_809647 | 1.90 |
ENST00000321153.4
|
RPLP2
|
ribosomal protein, large, P2 |
chr17_-_26694979 | 1.89 |
ENST00000438614.1
|
VTN
|
vitronectin |
chr8_+_9009296 | 1.89 |
ENST00000521718.1
|
RP11-10A14.4
|
Uncharacterized protein |
chr1_-_40041925 | 1.89 |
ENST00000372862.3
|
PABPC4
|
poly(A) binding protein, cytoplasmic 4 (inducible form) |
chr3_-_127542021 | 1.88 |
ENST00000434178.2
|
MGLL
|
monoglyceride lipase |
chr9_-_135545380 | 1.88 |
ENST00000544003.1
|
DDX31
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 31 |
chr10_-_120925054 | 1.88 |
ENST00000419372.1
ENST00000369131.4 ENST00000330036.6 ENST00000355697.2 |
SFXN4
|
sideroflexin 4 |
chr14_+_20923350 | 1.87 |
ENST00000555414.1
ENST00000216714.3 ENST00000553681.1 ENST00000557344.1 ENST00000398030.4 ENST00000557181.1 ENST00000555839.1 ENST00000553368.1 ENST00000556054.1 ENST00000557054.1 ENST00000557592.1 ENST00000557150.1 |
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1 |
chr2_+_239047337 | 1.87 |
ENST00000409223.1
ENST00000305959.4 |
KLHL30
|
kelch-like family member 30 |
chr16_+_215965 | 1.86 |
ENST00000356815.3
|
HBM
|
hemoglobin, mu |
chr11_-_61684962 | 1.86 |
ENST00000394836.2
|
RAB3IL1
|
RAB3A interacting protein (rabin3)-like 1 |
chr8_+_22132810 | 1.86 |
ENST00000356766.6
|
PIWIL2
|
piwi-like RNA-mediated gene silencing 2 |
chr17_+_49243639 | 1.85 |
ENST00000512737.1
ENST00000503064.1 |
NME1-NME2
|
NME1-NME2 readthrough |
chr20_-_44519839 | 1.84 |
ENST00000372518.4
|
NEURL2
|
neuralized E3 ubiquitin protein ligase 2 |
chr19_-_5720248 | 1.83 |
ENST00000360614.3
|
LONP1
|
lon peptidase 1, mitochondrial |
chr11_+_76494253 | 1.83 |
ENST00000333090.4
|
TSKU
|
tsukushi, small leucine rich proteoglycan |
chr19_+_10765614 | 1.83 |
ENST00000589283.1
|
ILF3
|
interleukin enhancer binding factor 3, 90kDa |
chr17_+_7477040 | 1.82 |
ENST00000581384.1
ENST00000577929.1 |
EIF4A1
|
eukaryotic translation initiation factor 4A1 |
chr16_+_89228757 | 1.82 |
ENST00000565008.1
|
LINC00304
|
long intergenic non-protein coding RNA 304 |
chr11_-_118972575 | 1.82 |
ENST00000432443.2
|
DPAGT1
|
dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase) |
chr9_+_92219919 | 1.81 |
ENST00000252506.6
ENST00000375769.1 |
GADD45G
|
growth arrest and DNA-damage-inducible, gamma |
chr19_+_42364460 | 1.81 |
ENST00000593863.1
|
RPS19
|
ribosomal protein S19 |
chr9_+_4792869 | 1.80 |
ENST00000381750.4
|
RCL1
|
RNA terminal phosphate cyclase-like 1 |
chr2_-_220083076 | 1.80 |
ENST00000295750.4
|
ABCB6
|
ATP-binding cassette, sub-family B (MDR/TAP), member 6 |
chr1_+_70876891 | 1.80 |
ENST00000411986.2
|
CTH
|
cystathionase (cystathionine gamma-lyase) |
chr17_+_4853442 | 1.80 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr7_-_1595107 | 1.79 |
ENST00000414730.1
|
TMEM184A
|
transmembrane protein 184A |
chr10_+_70715884 | 1.79 |
ENST00000354185.4
|
DDX21
|
DEAD (Asp-Glu-Ala-Asp) box helicase 21 |
chr2_-_242254595 | 1.79 |
ENST00000441124.1
ENST00000391976.2 |
HDLBP
|
high density lipoprotein binding protein |
chr22_+_35776828 | 1.78 |
ENST00000216117.8
|
HMOX1
|
heme oxygenase (decycling) 1 |
chr1_+_59762642 | 1.78 |
ENST00000371218.4
ENST00000303721.7 |
FGGY
|
FGGY carbohydrate kinase domain containing |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.1 | 12.2 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
2.8 | 8.4 | GO:1903410 | lysine import(GO:0034226) L-lysine import(GO:0061461) L-lysine import into cell(GO:1903410) |
2.0 | 20.4 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
1.7 | 5.0 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
1.6 | 4.8 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
1.6 | 4.7 | GO:0048627 | myoblast development(GO:0048627) |
1.5 | 7.6 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
1.5 | 7.4 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
1.4 | 4.2 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
1.4 | 6.9 | GO:0010902 | positive regulation of very-low-density lipoprotein particle remodeling(GO:0010902) |
1.3 | 3.8 | GO:0044205 | 'de novo' UMP biosynthetic process(GO:0044205) |
1.2 | 5.0 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
1.2 | 7.3 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
1.1 | 9.8 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
1.1 | 4.2 | GO:0060265 | positive regulation of respiratory burst involved in inflammatory response(GO:0060265) |
1.1 | 1.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.0 | 1.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
1.0 | 1.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) |
1.0 | 4.0 | GO:0009386 | translational attenuation(GO:0009386) |
1.0 | 3.0 | GO:0071629 | cytoplasm-associated proteasomal ubiquitin-dependent protein catabolic process(GO:0071629) |
1.0 | 3.9 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
1.0 | 6.7 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
0.9 | 13.9 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.9 | 2.8 | GO:0044209 | AMP salvage(GO:0044209) |
0.9 | 2.8 | GO:0045553 | TRAIL biosynthetic process(GO:0045553) regulation of TRAIL biosynthetic process(GO:0045554) positive regulation of TRAIL biosynthetic process(GO:0045556) |
0.9 | 1.8 | GO:0015917 | aminophospholipid transport(GO:0015917) |
0.9 | 6.2 | GO:0010133 | proline catabolic process to glutamate(GO:0010133) |
0.9 | 3.5 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.9 | 4.3 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
0.9 | 5.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.9 | 2.6 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.8 | 2.5 | GO:0018194 | N-terminal peptidyl-alanine methylation(GO:0018011) N-terminal peptidyl-alanine trimethylation(GO:0018012) N-terminal peptidyl-glycine methylation(GO:0018013) N-terminal peptidyl-proline dimethylation(GO:0018016) peptidyl-alanine modification(GO:0018194) N-terminal peptidyl-proline methylation(GO:0035568) N-terminal peptidyl-serine methylation(GO:0035570) N-terminal peptidyl-serine dimethylation(GO:0035572) N-terminal peptidyl-serine trimethylation(GO:0035573) |
0.8 | 2.5 | GO:0034970 | histone H3-R2 methylation(GO:0034970) |
0.8 | 3.9 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) |
0.8 | 3.8 | GO:0006127 | glycerophosphate shuttle(GO:0006127) |
0.8 | 3.0 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
0.7 | 3.5 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.7 | 3.5 | GO:0012502 | induction of programmed cell death(GO:0012502) positive regulation of apoptotic process in other organism(GO:0044533) positive regulation by symbiont of host programmed cell death(GO:0052042) positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052330) positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction(GO:0052501) |
0.7 | 6.3 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.7 | 2.7 | GO:1901895 | negative regulation of calcium-transporting ATPase activity(GO:1901895) |
0.7 | 2.7 | GO:0009224 | CMP salvage(GO:0006238) CMP biosynthetic process(GO:0009224) CMP metabolic process(GO:0046035) |
0.7 | 7.3 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.7 | 2.6 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.6 | 2.6 | GO:0019853 | L-ascorbic acid biosynthetic process(GO:0019853) |
0.6 | 1.9 | GO:0043181 | vacuolar sequestering(GO:0043181) |
0.6 | 6.3 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.6 | 1.9 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.6 | 4.8 | GO:0002378 | immunoglobulin biosynthetic process(GO:0002378) |
0.6 | 1.8 | GO:0015729 | thiosulfate transport(GO:0015709) oxaloacetate transport(GO:0015729) malate transport(GO:0015743) malate transmembrane transport(GO:0071423) oxaloacetate(2-) transmembrane transport(GO:1902356) |
0.6 | 0.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.6 | 3.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.6 | 1.8 | GO:0035281 | pre-miRNA export from nucleus(GO:0035281) |
0.6 | 0.6 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.6 | 2.8 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.6 | 6.2 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.6 | 1.7 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.6 | 3.9 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.5 | 2.7 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
0.5 | 1.1 | GO:0060435 | bronchiole development(GO:0060435) |
0.5 | 2.2 | GO:0032223 | negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
0.5 | 2.2 | GO:0019074 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.5 | 2.7 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
0.5 | 2.1 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.5 | 0.5 | GO:0007521 | muscle cell fate determination(GO:0007521) |
0.5 | 3.7 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.5 | 1.6 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.5 | 1.6 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.5 | 9.3 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.5 | 4.1 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
0.5 | 0.5 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.5 | 4.6 | GO:0036017 | response to erythropoietin(GO:0036017) |
0.5 | 4.1 | GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway(GO:2000323) |
0.5 | 4.0 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.5 | 6.0 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) |
0.5 | 5.0 | GO:0097647 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.5 | 3.0 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.5 | 2.5 | GO:0015862 | uridine transport(GO:0015862) |
0.5 | 2.9 | GO:1903436 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.5 | 2.0 | GO:0010983 | positive regulation of high-density lipoprotein particle clearance(GO:0010983) |
0.5 | 4.4 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.5 | 1.9 | GO:0009956 | radial pattern formation(GO:0009956) |
0.5 | 2.4 | GO:0009233 | menaquinone metabolic process(GO:0009233) |
0.5 | 5.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.5 | 1.9 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
0.5 | 0.9 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.5 | 2.3 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.5 | 3.3 | GO:0048241 | epinephrine transport(GO:0048241) |
0.5 | 0.9 | GO:0035359 | negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
0.5 | 1.4 | GO:0044179 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.5 | 2.3 | GO:0043323 | regulation of natural killer cell degranulation(GO:0043321) positive regulation of natural killer cell degranulation(GO:0043323) |
0.5 | 5.5 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.5 | 5.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.5 | 1.8 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.5 | 2.3 | GO:0009608 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.5 | 0.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.4 | 3.6 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.4 | 1.8 | GO:0006788 | heme oxidation(GO:0006788) negative regulation of mast cell cytokine production(GO:0032764) |
0.4 | 1.3 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
0.4 | 4.4 | GO:0046465 | dolichyl diphosphate biosynthetic process(GO:0006489) dolichyl diphosphate metabolic process(GO:0046465) |
0.4 | 7.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.4 | 6.9 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.4 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.4 | 1.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
0.4 | 1.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.4 | 1.3 | GO:0002101 | tRNA wobble cytosine modification(GO:0002101) |
0.4 | 1.7 | GO:0061743 | motor learning(GO:0061743) |
0.4 | 1.3 | GO:1904397 | negative regulation of neuromuscular junction development(GO:1904397) |
0.4 | 0.8 | GO:0097476 | spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
0.4 | 2.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.4 | 0.8 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.4 | 1.6 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.4 | 0.4 | GO:1904294 | positive regulation of ERAD pathway(GO:1904294) |
0.4 | 1.2 | GO:0050787 | detoxification of mercury ion(GO:0050787) |
0.4 | 2.0 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.4 | 4.4 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.4 | 1.2 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 1.2 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.4 | 1.6 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.4 | 2.7 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.4 | 1.2 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.4 | 1.5 | GO:0032915 | positive regulation of transforming growth factor beta2 production(GO:0032915) |
0.4 | 1.2 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.4 | 2.3 | GO:0048807 | female genitalia morphogenesis(GO:0048807) |
0.4 | 0.8 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.4 | 3.4 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.4 | 1.1 | GO:0072684 | mitochondrial tRNA 3'-trailer cleavage, endonucleolytic(GO:0072684) |
0.4 | 0.7 | GO:2000353 | positive regulation of epithelial cell apoptotic process(GO:1904037) positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.4 | 2.6 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
0.4 | 14.9 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.4 | 9.8 | GO:0006054 | N-acetylneuraminate metabolic process(GO:0006054) |
0.4 | 0.4 | GO:0042779 | tRNA 3'-trailer cleavage, endonucleolytic(GO:0034414) tRNA 3'-trailer cleavage(GO:0042779) |
0.4 | 5.4 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.4 | 1.1 | GO:0003169 | coronary vein morphogenesis(GO:0003169) cardiac vascular smooth muscle cell development(GO:0060948) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.4 | 5.0 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.4 | 1.4 | GO:0035948 | positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter(GO:0035948) |
0.4 | 2.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 0.7 | GO:0048477 | oogenesis(GO:0048477) |
0.4 | 6.7 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 2.1 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
0.3 | 3.5 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
0.3 | 5.2 | GO:0000050 | urea cycle(GO:0000050) |
0.3 | 2.4 | GO:0055129 | L-proline biosynthetic process(GO:0055129) |
0.3 | 0.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) cellular response to angiotensin(GO:1904385) response to angiotensin(GO:1990776) |
0.3 | 5.4 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) |
0.3 | 0.7 | GO:0071400 | cellular response to oleic acid(GO:0071400) |
0.3 | 3.6 | GO:0000466 | maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000466) |
0.3 | 1.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.3 | 2.6 | GO:0002005 | angiotensin catabolic process in blood(GO:0002005) |
0.3 | 1.0 | GO:0097187 | dentinogenesis(GO:0097187) |
0.3 | 1.6 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.3 | 1.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.3 | 6.2 | GO:0015684 | ferrous iron transport(GO:0015684) ferrous iron transmembrane transport(GO:1903874) |
0.3 | 1.3 | GO:0044211 | CTP salvage(GO:0044211) |
0.3 | 1.0 | GO:0034147 | regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) |
0.3 | 1.6 | GO:0008611 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.3 | 7.0 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.3 | 2.2 | GO:0031120 | snRNA pseudouridine synthesis(GO:0031120) |
0.3 | 0.9 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.3 | 2.2 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.3 | 3.1 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.3 | 0.6 | GO:0043335 | protein unfolding(GO:0043335) |
0.3 | 9.5 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
0.3 | 0.9 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
0.3 | 3.3 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 1.5 | GO:1904744 | positive regulation of telomeric DNA binding(GO:1904744) |
0.3 | 3.6 | GO:0031017 | exocrine pancreas development(GO:0031017) |
0.3 | 6.0 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
0.3 | 1.5 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.3 | 3.0 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.3 | 1.2 | GO:1903566 | ciliary basal body organization(GO:0032053) positive regulation of protein localization to cilium(GO:1903566) |
0.3 | 1.2 | GO:0019343 | cysteine biosynthetic process via cystathionine(GO:0019343) |
0.3 | 2.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.3 | 1.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.3 | 0.9 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.3 | 1.2 | GO:0010845 | positive regulation of reciprocal meiotic recombination(GO:0010845) negative regulation of histone phosphorylation(GO:0033128) |
0.3 | 2.3 | GO:2000857 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
0.3 | 1.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.3 | 3.8 | GO:0018202 | peptidyl-histidine modification(GO:0018202) |
0.3 | 0.3 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.3 | 0.6 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.3 | 4.3 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.3 | 4.0 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.3 | 1.4 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.3 | 3.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.3 | 0.9 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 1.1 | GO:0009298 | GDP-mannose biosynthetic process(GO:0009298) |
0.3 | 2.5 | GO:0031022 | nuclear migration along microfilament(GO:0031022) |
0.3 | 3.1 | GO:0032930 | positive regulation of superoxide anion generation(GO:0032930) |
0.3 | 1.1 | GO:1902943 | positive regulation of cyclic nucleotide-gated ion channel activity(GO:1902161) regulation of voltage-gated chloride channel activity(GO:1902941) positive regulation of voltage-gated chloride channel activity(GO:1902943) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.3 | 2.8 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.3 | 1.7 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.3 | 1.1 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
0.3 | 3.6 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
0.3 | 0.3 | GO:0036466 | synaptic vesicle recycling via endosome(GO:0036466) |
0.3 | 1.1 | GO:0072287 | metanephric distal tubule morphogenesis(GO:0072287) |
0.3 | 0.3 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.3 | 4.4 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.3 | 1.6 | GO:0045541 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.3 | 5.2 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.3 | 1.6 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 1.1 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.3 | 1.6 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.3 | 0.5 | GO:0071383 | cellular response to steroid hormone stimulus(GO:0071383) |
0.3 | 1.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 4.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.3 | 1.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.3 | 0.8 | GO:0033864 | positive regulation of NAD(P)H oxidase activity(GO:0033864) |
0.3 | 2.9 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 1.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.3 | 1.9 | GO:0071279 | cellular response to cobalt ion(GO:0071279) |
0.3 | 2.1 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.3 | 0.8 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.3 | 1.1 | GO:0000415 | negative regulation of histone H3-K36 methylation(GO:0000415) |
0.3 | 5.5 | GO:0002192 | IRES-dependent translational initiation(GO:0002192) |
0.3 | 1.6 | GO:0030581 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.3 | 0.8 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.3 | 1.3 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.3 | 1.0 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
0.3 | 0.5 | GO:1904869 | protein localization to nuclear body(GO:1903405) protein localization to Cajal body(GO:1904867) regulation of protein localization to Cajal body(GO:1904869) positive regulation of protein localization to Cajal body(GO:1904871) protein localization to nucleoplasm(GO:1990173) |
0.3 | 1.3 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.7 | GO:0016340 | calcium-dependent cell-matrix adhesion(GO:0016340) |
0.2 | 1.0 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.2 | 2.7 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.2 | 2.0 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.2 | 1.2 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 1.2 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.2 | 0.7 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.2 | 0.7 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.2 | 0.7 | GO:0014734 | skeletal muscle hypertrophy(GO:0014734) |
0.2 | 1.7 | GO:0019075 | virus maturation(GO:0019075) |
0.2 | 0.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) ascending aorta development(GO:0035905) ascending aorta morphogenesis(GO:0035910) |
0.2 | 4.3 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.2 | 4.0 | GO:0034134 | toll-like receptor 2 signaling pathway(GO:0034134) |
0.2 | 3.3 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.2 | 1.9 | GO:0010159 | specification of organ position(GO:0010159) |
0.2 | 1.4 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) |
0.2 | 0.7 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.2 | 0.9 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.2 | 0.7 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.2 | 2.3 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 1.2 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.2 | 1.4 | GO:0010193 | response to ozone(GO:0010193) |
0.2 | 2.8 | GO:2000622 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 1.4 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
0.2 | 1.4 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.2 | 0.7 | GO:0006288 | base-excision repair, DNA ligation(GO:0006288) |
0.2 | 0.5 | GO:0070781 | response to biotin(GO:0070781) |
0.2 | 0.4 | GO:1902080 | regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.2 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.2 | 1.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.2 | 0.7 | GO:0072738 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
0.2 | 0.4 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 0.9 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.2 | 1.8 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 0.7 | GO:0031126 | snoRNA 3'-end processing(GO:0031126) |
0.2 | 3.7 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.2 | 1.1 | GO:2000234 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
0.2 | 0.9 | GO:2000683 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) regulation of cellular response to X-ray(GO:2000683) positive regulation of cellular response to X-ray(GO:2000685) |
0.2 | 0.4 | GO:2000974 | negative regulation of pro-B cell differentiation(GO:2000974) |
0.2 | 0.6 | GO:0034059 | response to anoxia(GO:0034059) |
0.2 | 0.6 | GO:0014735 | regulation of muscle atrophy(GO:0014735) negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.2 | 0.6 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.2 | 2.8 | GO:0043473 | pigmentation(GO:0043473) |
0.2 | 4.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.2 | 1.1 | GO:0019918 | peptidyl-arginine methylation, to symmetrical-dimethyl arginine(GO:0019918) |
0.2 | 2.8 | GO:2000680 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.2 | 1.5 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.2 | 0.8 | GO:0032902 | nerve growth factor production(GO:0032902) |
0.2 | 4.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.2 | 1.0 | GO:0034124 | regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) |
0.2 | 0.4 | GO:0090149 | mitochondrial membrane fission(GO:0090149) |
0.2 | 0.2 | GO:0030908 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
0.2 | 3.3 | GO:0034375 | high-density lipoprotein particle remodeling(GO:0034375) |
0.2 | 1.7 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.2 | 2.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.2 | 1.2 | GO:0006014 | D-ribose metabolic process(GO:0006014) |
0.2 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.2 | 52.0 | GO:0006364 | rRNA processing(GO:0006364) |
0.2 | 1.0 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.2 | 1.4 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.2 | 0.8 | GO:0015883 | FAD transport(GO:0015883) FAD transmembrane transport(GO:0035350) |
0.2 | 7.4 | GO:0021680 | cerebellar Purkinje cell layer development(GO:0021680) |
0.2 | 0.6 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 0.4 | GO:0044416 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.2 | 0.8 | GO:0048200 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.2 | 0.8 | GO:0010980 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.2 | 0.6 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.2 | 0.6 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.2 | 1.0 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.2 | 1.2 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.2 | 0.8 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.2 | 1.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.2 | 0.2 | GO:0007595 | lactation(GO:0007595) |
0.2 | 1.5 | GO:0045007 | depurination(GO:0045007) |
0.2 | 0.6 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
0.2 | 2.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.2 | 1.7 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.2 | 0.8 | GO:0048539 | bone marrow development(GO:0048539) retinal blood vessel morphogenesis(GO:0061304) |
0.2 | 1.5 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
0.2 | 0.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.2 | 0.4 | GO:2001176 | mediator complex assembly(GO:0036034) regulation of mediator complex assembly(GO:2001176) positive regulation of mediator complex assembly(GO:2001178) |
0.2 | 0.6 | GO:0060838 | lymphatic endothelial cell fate commitment(GO:0060838) regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.9 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
0.2 | 0.9 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.2 | 0.7 | GO:0051583 | dopamine uptake involved in synaptic transmission(GO:0051583) catecholamine uptake involved in synaptic transmission(GO:0051934) catecholamine uptake(GO:0090493) dopamine uptake(GO:0090494) |
0.2 | 0.7 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.2 | 0.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.2 | 0.7 | GO:2001171 | positive regulation of ATP biosynthetic process(GO:2001171) |
0.2 | 0.9 | GO:1901094 | regulation of protein tetramerization(GO:1901090) negative regulation of protein tetramerization(GO:1901091) regulation of protein homotetramerization(GO:1901093) negative regulation of protein homotetramerization(GO:1901094) |
0.2 | 0.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.2 | 0.5 | GO:0016103 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
0.2 | 0.7 | GO:0090503 | RNA phosphodiester bond hydrolysis, exonucleolytic(GO:0090503) |
0.2 | 1.1 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.2 | 0.9 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.2 | 0.4 | GO:1902824 | regulation of late endosome to lysosome transport(GO:1902822) positive regulation of late endosome to lysosome transport(GO:1902824) |
0.2 | 5.1 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
0.2 | 1.2 | GO:0097473 | cellular response to high light intensity(GO:0071486) retinal rod cell apoptotic process(GO:0097473) |
0.2 | 0.4 | GO:0046041 | ITP metabolic process(GO:0046041) |
0.2 | 0.5 | GO:0042938 | dipeptide transport(GO:0042938) |
0.2 | 0.7 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
0.2 | 0.7 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.2 | 0.5 | GO:0014022 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.2 | 0.7 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 0.7 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 1.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.2 | 0.2 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.7 | GO:0002879 | positive regulation of acute inflammatory response to non-antigenic stimulus(GO:0002879) |
0.2 | 1.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.2 | 0.7 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.2 | 1.8 | GO:0072553 | terminal button organization(GO:0072553) |
0.2 | 1.0 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.2 | 1.8 | GO:0043587 | tongue morphogenesis(GO:0043587) |
0.2 | 0.2 | GO:0040031 | snRNA modification(GO:0040031) |
0.2 | 1.3 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 0.6 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.2 | 0.5 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.2 | 5.9 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.2 | 3.5 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.2 | 0.6 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.2 | 0.2 | GO:1903939 | regulation of TORC2 signaling(GO:1903939) |
0.2 | 1.1 | GO:0021546 | rhombomere development(GO:0021546) |
0.2 | 0.5 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.2 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.2 | 1.1 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.2 | 0.8 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 0.9 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.2 | 0.8 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
0.2 | 0.5 | GO:0002416 | IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
0.2 | 2.9 | GO:0036376 | sodium ion export from cell(GO:0036376) |
0.2 | 0.8 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.2 | 0.8 | GO:0071934 | thiamine transmembrane transport(GO:0071934) |
0.1 | 9.1 | GO:0006400 | tRNA modification(GO:0006400) |
0.1 | 0.6 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
0.1 | 1.9 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.1 | 0.6 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 0.6 | GO:0043376 | regulation of CD8-positive, alpha-beta T cell differentiation(GO:0043376) |
0.1 | 4.1 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.4 | GO:0071529 | cementum mineralization(GO:0071529) |
0.1 | 0.1 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
0.1 | 2.6 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 1.0 | GO:0008218 | bioluminescence(GO:0008218) |
0.1 | 0.9 | GO:0070272 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.7 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.1 | 0.9 | GO:1901490 | positive regulation of mast cell chemotaxis(GO:0060754) regulation of lymphangiogenesis(GO:1901490) |
0.1 | 0.9 | GO:0015911 | plasma membrane long-chain fatty acid transport(GO:0015911) |
0.1 | 0.7 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
0.1 | 0.3 | GO:1903721 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
0.1 | 0.9 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.1 | 0.8 | GO:0033132 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.1 | 0.1 | GO:0051549 | positive regulation of keratinocyte migration(GO:0051549) |
0.1 | 1.4 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.1 | 0.8 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.1 | 1.8 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.3 | GO:2000563 | positive regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000563) |
0.1 | 0.1 | GO:0010847 | regulation of chromatin assembly(GO:0010847) |
0.1 | 0.4 | GO:0060370 | susceptibility to T cell mediated cytotoxicity(GO:0060370) |
0.1 | 0.5 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 2.8 | GO:0034356 | NAD biosynthesis via nicotinamide riboside salvage pathway(GO:0034356) |
0.1 | 2.7 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.1 | 2.6 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.1 | 0.9 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.1 | 2.1 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 0.7 | GO:0016036 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.1 | 0.5 | GO:0090410 | malonate catabolic process(GO:0090410) |
0.1 | 0.3 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.3 | GO:0045875 | negative regulation of sister chromatid cohesion(GO:0045875) |
0.1 | 0.8 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.4 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 1.7 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 1.0 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.4 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.1 | 0.3 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.1 | 0.9 | GO:0071233 | cellular response to leucine(GO:0071233) |
0.1 | 0.1 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.5 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.4 | GO:1902570 | protein localization to nucleolus(GO:1902570) |
0.1 | 0.6 | GO:1904886 | beta-catenin destruction complex disassembly(GO:1904886) |
0.1 | 1.3 | GO:0002084 | protein depalmitoylation(GO:0002084) |
0.1 | 0.3 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.1 | 1.6 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.1 | 2.1 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.4 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 2.6 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.7 | GO:1904894 | positive regulation of JAK-STAT cascade(GO:0046427) positive regulation of STAT cascade(GO:1904894) |
0.1 | 1.7 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.6 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.1 | GO:0048633 | positive regulation of skeletal muscle tissue growth(GO:0048633) |
0.1 | 0.9 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.1 | 0.4 | GO:0072365 | regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter(GO:0072365) |
0.1 | 1.7 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 1.7 | GO:0070071 | proton-transporting two-sector ATPase complex assembly(GO:0070071) |
0.1 | 0.6 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.1 | 0.4 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 0.4 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.1 | 1.9 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
0.1 | 0.4 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.1 | 3.0 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 0.4 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 0.2 | GO:0060730 | regulation of intestinal epithelial structure maintenance(GO:0060730) |
0.1 | 5.4 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.1 | 1.5 | GO:0006406 | mRNA export from nucleus(GO:0006406) mRNA-containing ribonucleoprotein complex export from nucleus(GO:0071427) |
0.1 | 0.8 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.1 | 6.6 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 3.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 1.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.2 | GO:0098502 | DNA dephosphorylation(GO:0098502) |
0.1 | 1.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.1 | 0.7 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.1 | 3.5 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 0.8 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 2.4 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 1.5 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.1 | 2.3 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 1.4 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 2.9 | GO:0009303 | rRNA transcription(GO:0009303) |
0.1 | 0.2 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
0.1 | 0.6 | GO:0010822 | positive regulation of mitochondrion organization(GO:0010822) |
0.1 | 0.3 | GO:1903515 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) regulation of calcium ion-dependent exocytosis of neurotransmitter(GO:1903233) calcium ion transport from cytosol to endoplasmic reticulum(GO:1903515) |
0.1 | 0.3 | GO:0043407 | negative regulation of MAP kinase activity(GO:0043407) |
0.1 | 0.7 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 2.7 | GO:0048935 | peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
0.1 | 0.9 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.1 | 1.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.1 | 0.3 | GO:0036451 | cap mRNA methylation(GO:0036451) |
0.1 | 1.0 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.1 | 3.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 5.0 | GO:1903146 | regulation of mitophagy(GO:1903146) |
0.1 | 0.3 | GO:2001022 | positive regulation of response to DNA damage stimulus(GO:2001022) |
0.1 | 1.1 | GO:1900077 | negative regulation of insulin receptor signaling pathway(GO:0046627) negative regulation of cellular response to insulin stimulus(GO:1900077) |
0.1 | 0.3 | GO:0061184 | Spemann organizer formation(GO:0060061) positive regulation of dermatome development(GO:0061184) |
0.1 | 0.6 | GO:0051414 | response to cortisol(GO:0051414) |
0.1 | 2.0 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.1 | 2.8 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 0.5 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.1 | 1.8 | GO:0098779 | mitophagy in response to mitochondrial depolarization(GO:0098779) |
0.1 | 0.6 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 2.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 1.0 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
0.1 | 2.6 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
0.1 | 1.5 | GO:0006206 | pyrimidine nucleobase metabolic process(GO:0006206) |
0.1 | 0.4 | GO:0014806 | negative regulation of muscle hyperplasia(GO:0014740) smooth muscle hyperplasia(GO:0014806) |
0.1 | 0.7 | GO:0010225 | response to UV-C(GO:0010225) |
0.1 | 0.3 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.1 | 0.3 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
0.1 | 1.1 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.1 | 0.3 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.1 | 2.4 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.1 | 0.8 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 6.9 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 3.7 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.6 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.1 | 0.2 | GO:0044026 | DNA hypermethylation(GO:0044026) |
0.1 | 0.1 | GO:0000915 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
0.1 | 1.1 | GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
0.1 | 0.4 | GO:0042274 | ribosomal small subunit biogenesis(GO:0042274) |
0.1 | 0.3 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.1 | 2.5 | GO:0097421 | liver regeneration(GO:0097421) |
0.1 | 0.3 | GO:0070376 | regulation of ERK5 cascade(GO:0070376) negative regulation of ERK5 cascade(GO:0070377) |
0.1 | 1.6 | GO:0042737 | drug catabolic process(GO:0042737) |
0.1 | 11.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.8 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 2.5 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 1.6 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 5.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 1.1 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.7 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 2.5 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.1 | 0.5 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.1 | 2.8 | GO:0042254 | ribosome biogenesis(GO:0042254) |
0.1 | 0.7 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.3 | GO:0038086 | VEGF-activated platelet-derived growth factor receptor signaling pathway(GO:0038086) positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway(GO:0038091) |
0.1 | 1.1 | GO:0090151 | establishment of protein localization to mitochondrial membrane(GO:0090151) |
0.1 | 1.5 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.1 | 1.1 | GO:0001510 | RNA methylation(GO:0001510) |
0.1 | 1.6 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.1 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.4 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
0.1 | 1.9 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
0.1 | 2.7 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.7 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.1 | 0.2 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.1 | 1.0 | GO:0045717 | negative regulation of fatty acid biosynthetic process(GO:0045717) |
0.1 | 0.7 | GO:0010807 | regulation of synaptic vesicle priming(GO:0010807) |
0.1 | 0.4 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.1 | 0.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.1 | 1.6 | GO:0043981 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.1 | 0.4 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 2.8 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.1 | 0.6 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 1.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.1 | 3.3 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 5.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.1 | 1.8 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.1 | 2.5 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.1 | 2.3 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
0.1 | 0.9 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
0.1 | 1.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.1 | 0.4 | GO:0009177 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
0.1 | 0.3 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.1 | 0.6 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.1 | 1.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.1 | 0.3 | GO:2000254 | regulation of male germ cell proliferation(GO:2000254) |
0.1 | 1.7 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.1 | 0.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 1.6 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.1 | 0.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 0.4 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.1 | 1.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.1 | 0.5 | GO:0021517 | ventral spinal cord development(GO:0021517) |
0.1 | 0.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.1 | 1.6 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.2 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.1 | 4.7 | GO:0031100 | organ regeneration(GO:0031100) |
0.1 | 0.5 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.1 | 1.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.3 | GO:0006433 | prolyl-tRNA aminoacylation(GO:0006433) |
0.1 | 3.8 | GO:0071431 | tRNA export from nucleus(GO:0006409) tRNA transport(GO:0051031) tRNA-containing ribonucleoprotein complex export from nucleus(GO:0071431) |
0.1 | 0.8 | GO:0046325 | negative regulation of glucose import(GO:0046325) |
0.1 | 3.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.1 | 1.2 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.1 | 1.2 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.1 | 0.2 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 1.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.2 | GO:0061580 | colon epithelial cell migration(GO:0061580) |
0.1 | 1.3 | GO:0016576 | histone dephosphorylation(GO:0016576) |
0.1 | 0.2 | GO:0061110 | dense core granule biogenesis(GO:0061110) regulation of dense core granule biogenesis(GO:2000705) |
0.1 | 1.6 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.6 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.2 | GO:1990737 | response to manganese-induced endoplasmic reticulum stress(GO:1990737) |
0.1 | 1.2 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 2.3 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.1 | 1.3 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.7 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.1 | 1.0 | GO:0006228 | UTP biosynthetic process(GO:0006228) UTP metabolic process(GO:0046051) |
0.1 | 0.6 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.1 | 0.5 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.1 | 2.7 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.1 | 0.2 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 1.7 | GO:0051450 | myoblast proliferation(GO:0051450) |
0.1 | 0.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.1 | 0.9 | GO:0050909 | sensory perception of taste(GO:0050909) |
0.1 | 0.4 | GO:0035553 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.1 | 3.2 | GO:0005978 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.1 | 0.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 0.3 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.3 | GO:0002316 | follicular B cell differentiation(GO:0002316) |
0.1 | 1.8 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.1 | 0.2 | GO:0009912 | auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
0.1 | 0.3 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.1 | 1.4 | GO:0000338 | protein deneddylation(GO:0000338) |
0.1 | 0.3 | GO:0034350 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.1 | 1.4 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.1 | 0.1 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 6.6 | GO:0030433 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.3 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.4 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) |
0.1 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0044501 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.1 | 0.4 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.1 | 0.4 | GO:0014718 | positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
0.1 | 1.2 | GO:0039694 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.1 | 0.8 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 0.1 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.1 | 0.2 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 1.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.5 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
0.1 | 0.8 | GO:0032782 | bile acid secretion(GO:0032782) |
0.1 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.2 | GO:0010160 | sensory organ boundary specification(GO:0008052) formation of organ boundary(GO:0010160) taste bud development(GO:0061193) |
0.1 | 0.3 | GO:0002572 | pro-T cell differentiation(GO:0002572) regulation of pro-T cell differentiation(GO:2000174) positive regulation of pro-T cell differentiation(GO:2000176) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 2.7 | GO:0045672 | positive regulation of osteoclast differentiation(GO:0045672) |
0.1 | 0.2 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
0.1 | 0.3 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.1 | 0.3 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.1 | 3.9 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 0.3 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.1 | 0.3 | GO:0090669 | telomerase RNA stabilization(GO:0090669) |
0.1 | 0.6 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.1 | 1.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:1904247 | positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
0.1 | 0.2 | GO:1901052 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 3.4 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 0.3 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 2.2 | GO:0032201 | telomere maintenance via semi-conservative replication(GO:0032201) |
0.1 | 0.3 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 3.3 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.1 | 0.8 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.1 | 1.3 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.8 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.1 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
0.1 | 0.4 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.1 | 2.2 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.1 | 0.8 | GO:0015866 | ADP transport(GO:0015866) |
0.1 | 0.5 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
0.1 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
0.1 | 2.2 | GO:0006779 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.1 | 0.2 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.8 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.1 | 0.9 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.1 | 0.6 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.1 | GO:0010907 | positive regulation of glucose metabolic process(GO:0010907) |
0.1 | 1.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.9 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
0.1 | 2.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.1 | 0.3 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.1 | 0.3 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 2.2 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.2 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.1 | 0.1 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.1 | 1.3 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 4.5 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.7 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.1 | 0.4 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.3 | GO:0034770 | histone H4-K20 methylation(GO:0034770) |
0.1 | 1.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.1 | 0.4 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.2 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.1 | 0.5 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.1 | 0.3 | GO:0048496 | adherens junction maintenance(GO:0034334) maintenance of organ identity(GO:0048496) |
0.1 | 1.2 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.5 | GO:0043276 | anoikis(GO:0043276) |
0.1 | 0.2 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 5.8 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.6 | GO:1900045 | negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
0.1 | 0.2 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.6 | GO:0000082 | G1/S transition of mitotic cell cycle(GO:0000082) |
0.1 | 3.2 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.1 | 0.7 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
0.1 | 1.5 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
0.1 | 0.2 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.4 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.1 | 0.3 | GO:0048478 | replication fork protection(GO:0048478) |
0.1 | 0.1 | GO:0060447 | bud outgrowth involved in lung branching(GO:0060447) |
0.1 | 0.6 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) |
0.1 | 0.1 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.5 | GO:0007494 | midgut development(GO:0007494) |
0.1 | 0.2 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.1 | 0.5 | GO:2001012 | mesenchymal cell differentiation involved in kidney development(GO:0072161) mesenchymal cell differentiation involved in renal system development(GO:2001012) |
0.1 | 0.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
0.1 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.1 | 0.4 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) |
0.1 | 4.0 | GO:0055072 | iron ion homeostasis(GO:0055072) |
0.1 | 0.8 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.1 | 0.9 | GO:0006568 | tryptophan metabolic process(GO:0006568) |
0.1 | 0.1 | GO:0016322 | neuron remodeling(GO:0016322) |
0.1 | 0.5 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 1.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.1 | 2.7 | GO:0007050 | cell cycle arrest(GO:0007050) |
0.1 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.1 | 0.2 | GO:0007387 | anterior compartment pattern formation(GO:0007387) posterior compartment specification(GO:0007388) |
0.1 | 2.0 | GO:0031648 | protein destabilization(GO:0031648) |
0.1 | 5.1 | GO:0006413 | translational initiation(GO:0006413) |
0.1 | 2.0 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.1 | 0.4 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.1 | 0.5 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
0.1 | 0.1 | GO:0038178 | complement component C5a signaling pathway(GO:0038178) negative regulation of granulocyte chemotaxis(GO:0071623) negative regulation of neutrophil chemotaxis(GO:0090024) negative regulation of neutrophil migration(GO:1902623) |
0.1 | 0.6 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.8 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.1 | 1.1 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 1.1 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.1 | 0.5 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.1 | 1.8 | GO:1901998 | toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.1 | 0.4 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.4 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
0.1 | 0.1 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
0.0 | 0.3 | GO:0034627 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
0.0 | 1.2 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.3 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.7 | GO:0006907 | pinocytosis(GO:0006907) |
0.0 | 0.2 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.0 | 0.4 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.2 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
0.0 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.0 | 1.4 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.1 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
0.0 | 1.4 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.8 | GO:0051014 | actin filament severing(GO:0051014) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.5 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.0 | 0.9 | GO:0019915 | lipid storage(GO:0019915) |
0.0 | 0.2 | GO:1904357 | negative regulation of telomere maintenance via telomere lengthening(GO:1904357) |
0.0 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.0 | 0.3 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.0 | 0.7 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.0 | 0.8 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 2.9 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.4 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.0 | 1.1 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.0 | 0.8 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 2.0 | GO:0055092 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 0.3 | GO:0044375 | peroxisome membrane biogenesis(GO:0016557) regulation of peroxisome size(GO:0044375) |
0.0 | 0.1 | GO:0008057 | eye pigment granule organization(GO:0008057) |
0.0 | 0.5 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.0 | 0.2 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.0 | 0.2 | GO:0030578 | PML body organization(GO:0030578) |
0.0 | 1.2 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.0 | 1.0 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.0 | 0.0 | GO:0033594 | response to hydroxyisoflavone(GO:0033594) |
0.0 | 0.3 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.0 | 0.4 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.0 | 0.6 | GO:0000305 | response to oxygen radical(GO:0000305) |
0.0 | 2.9 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.6 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.0 | 0.2 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
0.0 | 0.2 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 1.0 | GO:0048286 | lung alveolus development(GO:0048286) |
0.0 | 0.1 | GO:0007538 | primary sex determination(GO:0007538) |
0.0 | 0.2 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.6 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.0 | 1.0 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) regulation of T cell homeostatic proliferation(GO:0046013) |
0.0 | 0.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.0 | 0.5 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.0 | 0.7 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.2 | GO:1902268 | polyamine transport(GO:0015846) polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) negative regulation of polyamine transmembrane transport(GO:1902268) |
0.0 | 0.3 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.0 | 0.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.0 | 0.1 | GO:0006499 | N-terminal protein myristoylation(GO:0006499) N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.0 | 0.1 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.0 | 1.0 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.8 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.0 | 0.3 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.1 | GO:0035623 | renal glucose absorption(GO:0035623) |
0.0 | 3.1 | GO:0010257 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.0 | 0.4 | GO:0061088 | regulation of sequestering of zinc ion(GO:0061088) |
0.0 | 0.1 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.1 | GO:1902177 | positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway(GO:1902177) |
0.0 | 0.1 | GO:0030853 | negative regulation of granulocyte differentiation(GO:0030853) |
0.0 | 1.0 | GO:0033198 | response to ATP(GO:0033198) |
0.0 | 0.4 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.0 | 0.7 | GO:1902229 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902229) |
0.0 | 1.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 1.5 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.0 | 0.0 | GO:0035357 | peroxisome proliferator activated receptor signaling pathway(GO:0035357) |
0.0 | 1.2 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 2.5 | GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle(GO:0051439) |
0.0 | 0.1 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.0 | 0.5 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 1.0 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.0 | GO:2000641 | regulation of early endosome to late endosome transport(GO:2000641) |
0.0 | 0.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.0 | 0.3 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.0 | 2.5 | GO:0046849 | bone remodeling(GO:0046849) |
0.0 | 0.5 | GO:0090520 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 1.9 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.0 | 0.1 | GO:0035407 | histone H3-T11 phosphorylation(GO:0035407) |
0.0 | 1.8 | GO:0051149 | positive regulation of muscle cell differentiation(GO:0051149) |
0.0 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 4.4 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.9 | GO:0043487 | regulation of RNA stability(GO:0043487) |
0.0 | 0.4 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.0 | 0.3 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
0.0 | 0.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.4 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.0 | 0.5 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.0 | 0.1 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.0 | 0.6 | GO:0045634 | regulation of melanocyte differentiation(GO:0045634) |
0.0 | 0.4 | GO:0002076 | osteoblast development(GO:0002076) |
0.0 | 0.3 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.0 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.0 | 0.3 | GO:0060613 | fat pad development(GO:0060613) |
0.0 | 0.8 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.0 | 0.1 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
0.0 | 0.3 | GO:2000142 | regulation of DNA-templated transcription, initiation(GO:2000142) |
0.0 | 0.9 | GO:0003151 | outflow tract morphogenesis(GO:0003151) |
0.0 | 0.2 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.0 | 1.3 | GO:0006336 | DNA replication-independent nucleosome assembly(GO:0006336) |
0.0 | 0.2 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
0.0 | 0.9 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
0.0 | 0.1 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.0 | 0.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.0 | 0.5 | GO:0015671 | oxygen transport(GO:0015671) |
0.0 | 0.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 1.3 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.1 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.0 | 1.9 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
0.0 | 0.2 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.0 | 0.1 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.2 | GO:0044241 | lipid digestion(GO:0044241) |
0.0 | 0.7 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.5 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.1 | GO:0031098 | stress-activated protein kinase signaling cascade(GO:0031098) |
0.0 | 0.1 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 2.6 | GO:0045087 | innate immune response(GO:0045087) |
0.0 | 0.2 | GO:0000821 | regulation of glutamine family amino acid metabolic process(GO:0000820) regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.3 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.0 | 0.3 | GO:0007405 | neuroblast proliferation(GO:0007405) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) cellular response to nitric oxide(GO:0071732) |
0.0 | 0.1 | GO:0019287 | isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.0 | 0.1 | GO:0072319 | vesicle uncoating(GO:0072319) |
0.0 | 0.5 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
0.0 | 0.2 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.0 | 2.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.3 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
0.0 | 0.6 | GO:0016246 | RNA interference(GO:0016246) |
0.0 | 0.2 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.0 | 0.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.0 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 2.3 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.3 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.0 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.0 | 0.3 | GO:0042026 | protein refolding(GO:0042026) |
0.0 | 0.2 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
0.0 | 0.2 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.0 | 0.3 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
0.0 | 0.3 | GO:0019359 | NAD biosynthetic process(GO:0009435) nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.0 | 0.9 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.0 | 0.1 | GO:0097167 | circadian regulation of translation(GO:0097167) |
0.0 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.8 | GO:0001706 | endoderm formation(GO:0001706) |
0.0 | 0.5 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.2 | GO:0006825 | copper ion transport(GO:0006825) |
0.0 | 0.4 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.7 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.0 | 0.4 | GO:0043030 | regulation of macrophage activation(GO:0043030) |
0.0 | 0.1 | GO:0035865 | cellular response to potassium ion(GO:0035865) |
0.0 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.0 | 0.1 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.0 | 0.2 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 0.6 | GO:0010830 | regulation of myotube differentiation(GO:0010830) |
0.0 | 0.0 | GO:0042262 | DNA protection(GO:0042262) |
0.0 | 0.1 | GO:0035188 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.0 | 0.1 | GO:0060314 | regulation of ryanodine-sensitive calcium-release channel activity(GO:0060314) |
0.0 | 0.4 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 1.7 | GO:0030574 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
0.0 | 1.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.0 | 0.1 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.0 | 0.4 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.0 | 0.0 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.0 | 0.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.0 | 0.8 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 0.3 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.0 | 0.3 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.0 | 1.1 | GO:1901568 | icosanoid metabolic process(GO:0006690) fatty acid derivative metabolic process(GO:1901568) |
0.0 | 0.1 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 0.3 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.3 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.0 | 0.0 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 0.4 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.6 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
0.0 | 0.1 | GO:1902369 | negative regulation of RNA catabolic process(GO:1902369) negative regulation of mRNA catabolic process(GO:1902373) |
0.0 | 0.6 | GO:0046856 | phospholipid dephosphorylation(GO:0046839) phosphatidylinositol dephosphorylation(GO:0046856) |
0.0 | 0.2 | GO:0030099 | myeloid cell differentiation(GO:0030099) |
0.0 | 0.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.5 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
0.0 | 0.4 | GO:0046716 | muscle cell cellular homeostasis(GO:0046716) |
0.0 | 0.5 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.0 | 0.3 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.0 | 0.5 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0010324 | phagocytosis, engulfment(GO:0006911) membrane invagination(GO:0010324) |
0.0 | 0.5 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.0 | 0.2 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.2 | GO:1903830 | magnesium ion transmembrane transport(GO:1903830) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 1.0 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.0 | 0.7 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 0.1 | GO:0033512 | L-lysine catabolic process to acetyl-CoA via saccharopine(GO:0033512) |
0.0 | 0.4 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.4 | GO:0034694 | response to prostaglandin(GO:0034694) |
0.0 | 0.1 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.0 | 0.0 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.0 | 0.1 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
0.0 | 1.0 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.4 | GO:2001244 | positive regulation of intrinsic apoptotic signaling pathway(GO:2001244) |
0.0 | 0.2 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.0 | 0.4 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) |
0.0 | 0.2 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.0 | 0.4 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 1.2 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.8 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) cellular response to interleukin-12(GO:0071349) |
0.0 | 0.2 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.1 | GO:0006623 | protein targeting to vacuole(GO:0006623) |
0.0 | 0.1 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.0 | 0.6 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.0 | 0.0 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.0 | 0.2 | GO:0030968 | endoplasmic reticulum unfolded protein response(GO:0030968) |
0.0 | 0.5 | GO:0032508 | DNA duplex unwinding(GO:0032508) |
0.0 | 0.1 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.1 | GO:0090155 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
0.0 | 0.3 | GO:0010259 | multicellular organism aging(GO:0010259) |
0.0 | 0.2 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.0 | 0.9 | GO:0046426 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
0.0 | 0.2 | GO:0050850 | positive regulation of calcium-mediated signaling(GO:0050850) |
0.0 | 0.0 | GO:0097676 | uterus morphogenesis(GO:0061038) histone H3-K36 dimethylation(GO:0097676) |
0.0 | 0.1 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.0 | 0.1 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.3 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 0.3 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.9 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.6 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.7 | GO:0002250 | adaptive immune response(GO:0002250) |
0.0 | 0.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.1 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.0 | 0.2 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.0 | 0.0 | GO:0060629 | regulation of homologous chromosome segregation(GO:0060629) |
0.0 | 0.7 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.0 | 0.3 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.0 | 0.2 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.4 | GO:0042220 | response to cocaine(GO:0042220) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.3 | GO:0034629 | cellular protein complex localization(GO:0034629) |
0.0 | 0.2 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.0 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.0 | 0.0 | GO:0036065 | fucosylation(GO:0036065) |
0.0 | 0.1 | GO:0048757 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.1 | GO:0002504 | antigen processing and presentation of peptide antigen via MHC class II(GO:0002495) antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.0 | 0.1 | GO:0045022 | early endosome to late endosome transport(GO:0045022) |
0.0 | 0.3 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.0 | 0.0 | GO:0007292 | female gamete generation(GO:0007292) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 15.0 | GO:0070552 | BRISC complex(GO:0070552) |
1.1 | 4.6 | GO:0031084 | BLOC-2 complex(GO:0031084) |
1.1 | 9.1 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.9 | 2.8 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.9 | 6.9 | GO:0031415 | NatA complex(GO:0031415) |
0.9 | 12.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.8 | 3.9 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.7 | 3.7 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.7 | 5.0 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.7 | 9.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.7 | 18.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.7 | 2.7 | GO:1990923 | PET complex(GO:1990923) |
0.6 | 1.9 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.6 | 1.9 | GO:0030689 | Noc complex(GO:0030689) |
0.6 | 6.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.6 | 6.0 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.6 | 1.8 | GO:0042565 | RNA nuclear export complex(GO:0042565) |
0.6 | 1.7 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.6 | 1.7 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.5 | 2.7 | GO:0097452 | GAIT complex(GO:0097452) |
0.5 | 3.7 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.5 | 2.6 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.5 | 3.0 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.5 | 1.0 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.5 | 1.9 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 4.8 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
0.4 | 2.5 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.4 | 4.9 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.4 | 2.8 | GO:0090661 | box H/ACA scaRNP complex(GO:0072589) box H/ACA telomerase RNP complex(GO:0090661) |
0.4 | 6.9 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.4 | 1.2 | GO:0034455 | t-UTP complex(GO:0034455) |
0.4 | 1.2 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.4 | 2.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.4 | 2.0 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.4 | 6.5 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.4 | 13.0 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.4 | 19.2 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.4 | 5.2 | GO:0042587 | glycogen granule(GO:0042587) |
0.4 | 2.1 | GO:0045323 | interleukin-1 receptor complex(GO:0045323) |
0.4 | 2.5 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.3 | 4.1 | GO:0097504 | Gemini of coiled bodies(GO:0097504) |
0.3 | 4.3 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.3 | 3.0 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 1.5 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.3 | 4.3 | GO:0030686 | 90S preribosome(GO:0030686) |
0.3 | 2.5 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.3 | 4.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 31.5 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.3 | 3.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.7 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.3 | 2.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.3 | 2.1 | GO:0070876 | SOSS complex(GO:0070876) |
0.3 | 4.0 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 1.7 | GO:0061617 | MICOS complex(GO:0061617) |
0.2 | 0.5 | GO:0031045 | dense core granule(GO:0031045) |
0.2 | 11.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.2 | 3.1 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.2 | 2.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.6 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.2 | 0.7 | GO:0070685 | macropinocytic cup(GO:0070685) |
0.2 | 1.4 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 6.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.2 | 1.3 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
0.2 | 1.7 | GO:0005694 | chromosome(GO:0005694) |
0.2 | 1.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.5 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.2 | 12.7 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.2 | 0.9 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.2 | 2.1 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
0.2 | 4.0 | GO:0034709 | methylosome(GO:0034709) |
0.2 | 4.4 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 0.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.2 | 2.1 | GO:0032010 | phagolysosome(GO:0032010) |
0.2 | 0.8 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 1.0 | GO:0002133 | polycystin complex(GO:0002133) |
0.2 | 2.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.2 | 0.6 | GO:0005584 | collagen type I trimer(GO:0005584) |
0.2 | 0.8 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.2 | 1.7 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
0.2 | 0.6 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.2 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.2 | 5.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) |
0.2 | 1.1 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.2 | 0.9 | GO:0032449 | CBM complex(GO:0032449) |
0.2 | 0.7 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 3.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
0.2 | 1.3 | GO:0031519 | PcG protein complex(GO:0031519) |
0.2 | 0.9 | GO:0071942 | XPC complex(GO:0071942) |
0.2 | 2.7 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.2 | 1.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.2 | 2.8 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.2 | 1.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 0.9 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.2 | 1.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.2 | 4.7 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.2 | 2.3 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.1 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.2 | 1.4 | GO:0031931 | TORC1 complex(GO:0031931) |
0.2 | 1.6 | GO:0005827 | polar microtubule(GO:0005827) |
0.2 | 2.5 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.2 | 1.1 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.2 | 0.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.1 | 9.8 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 2.5 | GO:0019774 | proteasome core complex, beta-subunit complex(GO:0019774) |
0.1 | 2.9 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.1 | 1.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.1 | 2.0 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 20.4 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 11.6 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 2.0 | GO:0043083 | synaptic cleft(GO:0043083) |
0.1 | 0.4 | GO:0009346 | citrate lyase complex(GO:0009346) |
0.1 | 1.9 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 8.7 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.1 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.7 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.1 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.1 | 1.8 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.1 | 0.9 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.1 | 0.6 | GO:0098576 | lumenal side of membrane(GO:0098576) |
0.1 | 0.6 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 1.9 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.1 | 0.7 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.4 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 9.2 | GO:0005762 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.1 | 3.0 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.8 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.6 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 9.1 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.1 | 0.3 | GO:0005745 | m-AAA complex(GO:0005745) |
0.1 | 1.4 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.1 | 0.6 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
0.1 | 1.9 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.8 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
0.1 | 0.5 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.1 | 0.6 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.1 | 0.4 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.1 | 0.3 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.1 | 0.9 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.2 | GO:0033503 | HULC complex(GO:0033503) |
0.1 | 0.3 | GO:0043511 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 1.0 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.1 | 0.6 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.1 | 1.2 | GO:0072487 | MSL complex(GO:0072487) |
0.1 | 3.6 | GO:0097526 | spliceosomal tri-snRNP complex(GO:0097526) |
0.1 | 2.0 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.1 | 2.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.1 | 1.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 3.4 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.1 | 1.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 3.5 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.1 | 1.0 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.1 | 2.6 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 0.3 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.1 | 2.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.1 | 1.2 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.8 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.1 | 1.4 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 2.3 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.1 | 9.1 | GO:0031970 | organelle envelope lumen(GO:0031970) |
0.1 | 0.5 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0030956 | glutamyl-tRNA(Gln) amidotransferase complex(GO:0030956) |
0.1 | 0.2 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
0.1 | 0.2 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 1.3 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.1 | 0.2 | GO:0000125 | PCAF complex(GO:0000125) |
0.1 | 0.7 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.1 | 3.6 | GO:0090545 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
0.1 | 0.7 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.3 | GO:0097361 | CIA complex(GO:0097361) |
0.1 | 1.4 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 2.0 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 4.7 | GO:0005840 | ribosome(GO:0005840) |
0.1 | 18.5 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.1 | 7.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 0.6 | GO:1990130 | Iml1 complex(GO:1990130) |
0.1 | 1.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.1 | 2.1 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 2.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 1.0 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 1.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.1 | 0.6 | GO:0000791 | euchromatin(GO:0000791) |
0.1 | 0.4 | GO:0009328 | phenylalanine-tRNA ligase complex(GO:0009328) |
0.1 | 0.9 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.1 | 1.3 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.1 | 13.5 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 33.6 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 1.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.8 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 4.5 | GO:0005771 | multivesicular body(GO:0005771) |
0.1 | 3.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.1 | 2.5 | GO:0005844 | polysome(GO:0005844) |
0.1 | 0.4 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.1 | 0.3 | GO:0097196 | Shu complex(GO:0097196) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 2.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.1 | 0.3 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.1 | 0.5 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.1 | 0.6 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 1.1 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
0.1 | 1.1 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.1 | 0.7 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.1 | 0.9 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.2 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.1 | 5.0 | GO:0005811 | lipid particle(GO:0005811) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.5 | GO:0044294 | dendritic growth cone(GO:0044294) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 13.7 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.1 | 0.3 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.1 | 0.5 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.4 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.4 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.1 | 0.1 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 0.2 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.5 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 0.5 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 1.4 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 0.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 22.2 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 4.5 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 1.5 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.3 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 1.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.7 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 4.7 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 13.1 | GO:0005667 | transcription factor complex(GO:0005667) |
0.0 | 3.9 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.6 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.0 | 0.1 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.0 | 5.1 | GO:0072686 | mitotic spindle(GO:0072686) |
0.0 | 1.9 | GO:0000123 | histone acetyltransferase complex(GO:0000123) |
0.0 | 0.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 0.2 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.0 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.0 | 4.1 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 1.2 | GO:0032156 | septin cytoskeleton(GO:0032156) |
0.0 | 0.7 | GO:0030008 | TRAPP complex(GO:0030008) |
0.0 | 52.9 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.3 | GO:0033263 | CORVET complex(GO:0033263) |
0.0 | 1.3 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 1.1 | GO:0032982 | myosin filament(GO:0032982) |
0.0 | 0.3 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.3 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.0 | 0.7 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.0 | 0.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.0 | 1.2 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.0 | 1.5 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 38.4 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 0.2 | GO:0055087 | Ski complex(GO:0055087) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 4.3 | GO:1904813 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.3 | GO:0043196 | varicosity(GO:0043196) |
0.0 | 0.2 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.0 | 0.4 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.0 | 7.6 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 1.1 | GO:0034706 | sodium channel complex(GO:0034706) |
0.0 | 0.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 0.2 | GO:0014802 | terminal cisterna(GO:0014802) |
0.0 | 1.9 | GO:0035577 | azurophil granule membrane(GO:0035577) |
0.0 | 0.5 | GO:0031904 | endosome lumen(GO:0031904) |
0.0 | 0.1 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.2 | GO:0000407 | pre-autophagosomal structure(GO:0000407) |
0.0 | 0.2 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.4 | GO:0000445 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 1.5 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.3 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.0 | 0.1 | GO:0035838 | growing cell tip(GO:0035838) |
0.0 | 2.1 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.1 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.0 | 5.6 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:0032021 | NELF complex(GO:0032021) |
0.0 | 0.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.0 | 0.6 | GO:0005639 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.0 | 0.4 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.0 | 4.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 1.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.8 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.5 | GO:0005685 | U1 snRNP(GO:0005685) |
0.0 | 0.1 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 20.7 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 0.5 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.0 | 0.3 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.0 | 0.4 | GO:0000800 | lateral element(GO:0000800) |
0.0 | 0.2 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.0 | 0.5 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.0 | 2.0 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.4 | GO:0000242 | pericentriolar material(GO:0000242) |
0.0 | 3.1 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 3.2 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.1 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.0 | 0.9 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.0 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.0 | 0.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.0 | GO:0005713 | recombination nodule(GO:0005713) |
0.0 | 0.5 | GO:0101003 | ficolin-1-rich granule membrane(GO:0101003) |
0.0 | 0.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.4 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 0.4 | GO:0036019 | endolysosome(GO:0036019) |
0.0 | 1.1 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.1 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.0 | 0.5 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.4 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.0 | 0.4 | GO:0044439 | microbody part(GO:0044438) peroxisomal part(GO:0044439) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 0.6 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.4 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 36.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.5 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.4 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 2.1 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 18.3 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.7 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.0 | GO:0005682 | U5 snRNP(GO:0005682) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.3 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
2.0 | 20.4 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
1.7 | 8.4 | GO:0005287 | high-affinity basic amino acid transmembrane transporter activity(GO:0005287) high-affinity arginine transmembrane transporter activity(GO:0005289) high-affinity lysine transmembrane transporter activity(GO:0005292) |
1.7 | 5.0 | GO:0070361 | mitochondrial light strand promoter anti-sense binding(GO:0070361) mitochondrial heavy strand promoter anti-sense binding(GO:0070362) mitochondrial heavy strand promoter sense binding(GO:0070364) |
1.6 | 4.8 | GO:0004326 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
1.5 | 4.6 | GO:0003842 | 1-pyrroline-5-carboxylate dehydrogenase activity(GO:0003842) |
1.4 | 6.9 | GO:0004461 | lactose synthase activity(GO:0004461) |
1.2 | 5.0 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
1.2 | 3.7 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.2 | 7.3 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
1.2 | 3.6 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
1.2 | 8.2 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.1 | 6.6 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
1.1 | 3.3 | GO:0019150 | D-ribulokinase activity(GO:0019150) |
1.1 | 3.3 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.9 | 2.8 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.9 | 2.8 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.9 | 9.1 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.8 | 3.4 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.8 | 1.6 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.8 | 2.4 | GO:0004766 | spermidine synthase activity(GO:0004766) |
0.8 | 3.9 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
0.8 | 3.8 | GO:0004368 | glycerol-3-phosphate dehydrogenase activity(GO:0004368) oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.8 | 3.0 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.7 | 18.6 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.7 | 5.0 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.7 | 7.1 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.7 | 2.1 | GO:0047280 | nicotinamide phosphoribosyltransferase activity(GO:0047280) |
0.6 | 2.5 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.6 | 3.1 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.6 | 3.1 | GO:0033265 | choline binding(GO:0033265) |
0.6 | 5.5 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.6 | 1.8 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.6 | 3.0 | GO:0034584 | piRNA binding(GO:0034584) |
0.6 | 1.8 | GO:0015117 | thiosulfate transmembrane transporter activity(GO:0015117) oxaloacetate transmembrane transporter activity(GO:0015131) |
0.6 | 2.4 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
0.6 | 1.8 | GO:0090631 | pre-miRNA transporter activity(GO:0090631) |
0.6 | 2.4 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.6 | 2.4 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.6 | 2.3 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.6 | 2.3 | GO:0003976 | UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity(GO:0003976) |
0.6 | 2.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
0.5 | 5.5 | GO:0003835 | beta-galactoside alpha-2,6-sialyltransferase activity(GO:0003835) |
0.5 | 2.2 | GO:0004104 | acetylcholinesterase activity(GO:0003990) cholinesterase activity(GO:0004104) |
0.5 | 1.6 | GO:0043849 | Ras palmitoyltransferase activity(GO:0043849) |
0.5 | 2.2 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.5 | 2.7 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.5 | 3.7 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.5 | 2.1 | GO:0005277 | acetylcholine transmembrane transporter activity(GO:0005277) acetate ester transmembrane transporter activity(GO:1901375) |
0.5 | 3.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.5 | 16.0 | GO:0043495 | protein anchor(GO:0043495) |
0.5 | 9.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.5 | 1.5 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.5 | 1.9 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
0.5 | 2.9 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.5 | 1.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.5 | 6.2 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.5 | 1.4 | GO:0008746 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.5 | 1.4 | GO:0003826 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.5 | 1.4 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.4 | 1.8 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.4 | 6.6 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.4 | 2.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.4 | 2.6 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.4 | 1.7 | GO:0004031 | aldehyde oxidase activity(GO:0004031) |
0.4 | 1.3 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.4 | 1.7 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.4 | 1.3 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.4 | 1.7 | GO:0034057 | RNA strand-exchange activity(GO:0034057) |
0.4 | 2.5 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.4 | 5.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
0.4 | 1.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.4 | 6.1 | GO:0008097 | 5S rRNA binding(GO:0008097) |
0.4 | 4.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.4 | 2.0 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.4 | 1.6 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.4 | 1.6 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.4 | 1.6 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.4 | 1.2 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
0.4 | 1.2 | GO:0004938 | alpha2-adrenergic receptor activity(GO:0004938) |
0.4 | 4.3 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 1.2 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
0.4 | 1.6 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 7.0 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.4 | 1.2 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.4 | 1.5 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.4 | 1.5 | GO:0042781 | 3'-tRNA processing endoribonuclease activity(GO:0042781) |
0.4 | 1.1 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.4 | 0.4 | GO:0051185 | coenzyme transporter activity(GO:0051185) |
0.4 | 5.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.4 | 1.1 | GO:0048244 | phytanoyl-CoA dioxygenase activity(GO:0048244) |
0.4 | 0.4 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.4 | 2.1 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 3.8 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.3 | 1.7 | GO:0004419 | hydroxymethylglutaryl-CoA lyase activity(GO:0004419) |
0.3 | 7.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.3 | 2.4 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 2.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.3 | 2.0 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.3 | 2.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.3 | 3.3 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.3 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.3 | 1.9 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.3 | 0.9 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.3 | 1.2 | GO:0045131 | pre-mRNA branch point binding(GO:0045131) |
0.3 | 1.8 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 0.9 | GO:0005010 | insulin-like growth factor-activated receptor activity(GO:0005010) |
0.3 | 1.2 | GO:0070025 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.3 | 1.2 | GO:0032406 | MutLbeta complex binding(GO:0032406) MutSbeta complex binding(GO:0032408) |
0.3 | 2.4 | GO:0004331 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.3 | 1.2 | GO:0019862 | IgA binding(GO:0019862) |
0.3 | 1.2 | GO:0016435 | rRNA (guanine) methyltransferase activity(GO:0016435) |
0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 2.6 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.3 | 1.1 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 2.8 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.3 | 5.1 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.3 | 3.7 | GO:0043199 | sulfate binding(GO:0043199) |
0.3 | 2.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.3 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.3 | 1.1 | GO:0005260 | channel-conductance-controlling ATPase activity(GO:0005260) |
0.3 | 1.1 | GO:0004822 | isoleucine-tRNA ligase activity(GO:0004822) |
0.3 | 0.8 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.3 | 9.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 1.1 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.3 | 1.6 | GO:0008479 | queuine tRNA-ribosyltransferase activity(GO:0008479) |
0.3 | 0.8 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.3 | 1.3 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 9.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.3 | 2.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 4.7 | GO:0016885 | ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.3 | 1.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.3 | 0.8 | GO:1902271 | D3 vitamins binding(GO:1902271) |
0.3 | 3.6 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.3 | 3.8 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.3 | 0.8 | GO:0043337 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity(GO:0043337) |
0.3 | 0.8 | GO:1904928 | coreceptor activity involved in canonical Wnt signaling pathway(GO:1904928) |
0.2 | 3.7 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.2 | 2.2 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.2 | 2.9 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.2 | 0.7 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 0.7 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.2 | 0.9 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 0.7 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
0.2 | 0.7 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 1.9 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.2 | 1.4 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
0.2 | 0.7 | GO:0004040 | amidase activity(GO:0004040) |
0.2 | 0.7 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
0.2 | 0.5 | GO:0038052 | RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding(GO:0038052) |
0.2 | 2.7 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 2.3 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.2 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.2 | 2.5 | GO:0004032 | alditol:NADP+ 1-oxidoreductase activity(GO:0004032) |
0.2 | 2.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 5.1 | GO:0030515 | snoRNA binding(GO:0030515) |
0.2 | 0.7 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.2 | 3.5 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.2 | 5.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.2 | 0.9 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.2 | 1.1 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 0.6 | GO:0004584 | dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity(GO:0004584) |
0.2 | 5.3 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.2 | 49.6 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.2 | 1.3 | GO:0015333 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
0.2 | 0.6 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
0.2 | 1.5 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.2 | 2.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.2 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 0.8 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
0.2 | 0.2 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.2 | 0.8 | GO:0015230 | FAD transmembrane transporter activity(GO:0015230) |
0.2 | 1.8 | GO:0043426 | MRF binding(GO:0043426) |
0.2 | 0.6 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.2 | 1.2 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
0.2 | 1.4 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.2 | 1.0 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.2 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 0.6 | GO:0030272 | cyclo-ligase activity(GO:0016882) 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.2 | 3.0 | GO:0043995 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.2 | 1.7 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.2 | 0.7 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
0.2 | 0.6 | GO:0008517 | folic acid transporter activity(GO:0008517) |
0.2 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.9 | GO:0031208 | POZ domain binding(GO:0031208) |
0.2 | 1.1 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.2 | 0.7 | GO:0005334 | norepinephrine:sodium symporter activity(GO:0005334) |
0.2 | 5.7 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.2 | 1.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 1.1 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.2 | 0.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 0.9 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.2 | 0.9 | GO:0004572 | mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity(GO:0004572) |
0.2 | 1.2 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
0.2 | 3.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.2 | 0.5 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.2 | 0.7 | GO:0001595 | angiotensin receptor activity(GO:0001595) angiotensin type II receptor activity(GO:0004945) |
0.2 | 1.5 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
0.2 | 3.0 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.2 | 0.5 | GO:0019961 | interferon binding(GO:0019961) |
0.2 | 0.7 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
0.2 | 1.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.2 | 8.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 9.1 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.2 | 6.0 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.2 | 0.7 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 1.6 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
0.2 | 5.1 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.2 | 0.5 | GO:1904713 | beta-catenin destruction complex binding(GO:1904713) |
0.2 | 6.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.2 | 0.6 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.2 | 0.6 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 5.4 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.6 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 3.2 | GO:0019841 | retinol binding(GO:0019841) |
0.2 | 0.5 | GO:0036440 | citrate (Si)-synthase activity(GO:0004108) citrate synthase activity(GO:0036440) |
0.2 | 0.8 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.2 | 0.3 | GO:0004530 | deoxyribonuclease I activity(GO:0004530) |
0.2 | 1.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.2 | 0.8 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.2 | 1.1 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.2 | 1.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 2.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) arachidonic acid epoxygenase activity(GO:0008392) |
0.2 | 0.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.2 | 11.2 | GO:0070888 | E-box binding(GO:0070888) |
0.1 | 1.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 1.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.1 | 1.2 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.1 | 2.0 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) |
0.1 | 2.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.1 | 4.0 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.3 | GO:0045142 | triplex DNA binding(GO:0045142) |
0.1 | 0.9 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.4 | GO:0034041 | sterol-transporting ATPase activity(GO:0034041) |
0.1 | 0.7 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
0.1 | 0.6 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 0.1 | GO:0004827 | proline-tRNA ligase activity(GO:0004827) |
0.1 | 3.6 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 0.4 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
0.1 | 1.5 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.1 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.1 | 0.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.7 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.1 | 2.5 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 8.9 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.1 | 0.5 | GO:0090409 | malonyl-CoA synthetase activity(GO:0090409) |
0.1 | 1.8 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.1 | 0.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
0.1 | 2.3 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 1.2 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.1 | 1.2 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.3 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.1 | 2.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.1 | 1.3 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.1 | 0.4 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.1 | 1.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.8 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.6 | GO:0019956 | chemokine binding(GO:0019956) |
0.1 | 0.6 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.1 | 1.1 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 2.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 3.3 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.5 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 1.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 3.7 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.1 | 1.4 | GO:0000990 | transcription factor activity, core RNA polymerase binding(GO:0000990) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 2.1 | GO:0008494 | translation activator activity(GO:0008494) |
0.1 | 0.6 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.6 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.1 | 1.4 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.6 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.1 | 1.0 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 4.2 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.2 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 4.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 2.9 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0031775 | lutropin-choriogonadotropic hormone receptor binding(GO:0031775) calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential(GO:0086039) |
0.1 | 2.5 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.1 | 0.8 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.1 | 1.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.1 | 1.3 | GO:0010181 | FMN binding(GO:0010181) |
0.1 | 2.5 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.1 | 0.3 | GO:0004583 | dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity(GO:0004583) |
0.1 | 1.0 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.1 | 3.1 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.1 | 0.3 | GO:0016855 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.1 | 0.5 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.1 | 2.8 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 5.3 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 0.3 | GO:0015218 | pyrimidine nucleotide transmembrane transporter activity(GO:0015218) |
0.1 | 0.9 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.1 | 1.3 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.1 | 1.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 2.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 1.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.1 | 0.9 | GO:0070740 | tubulin-glutamic acid ligase activity(GO:0070740) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 1.6 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 0.3 | GO:0005174 | CD40 receptor binding(GO:0005174) |
0.1 | 0.9 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.1 | 0.6 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.1 | 0.9 | GO:0019798 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.1 | 0.5 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.1 | 0.3 | GO:0016898 | D-lactate dehydrogenase (cytochrome) activity(GO:0004458) oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor(GO:0016898) |
0.1 | 0.7 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 0.6 | GO:0042806 | fucose binding(GO:0042806) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.9 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
0.1 | 0.4 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.1 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 3.7 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.1 | 4.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.1 | 0.3 | GO:0004597 | peptide-aspartate beta-dioxygenase activity(GO:0004597) |
0.1 | 1.2 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 12.8 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 1.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.1 | 0.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.5 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.1 | 4.2 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.1 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.1 | 1.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 1.7 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.1 | 4.5 | GO:0031624 | ubiquitin conjugating enzyme binding(GO:0031624) |
0.1 | 1.3 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.1 | 0.5 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.5 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.1 | 4.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.1 | 5.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.7 | GO:0034711 | inhibin binding(GO:0034711) |
0.1 | 3.6 | GO:0003951 | NAD+ kinase activity(GO:0003951) |
0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.1 | GO:0015234 | thiamine transmembrane transporter activity(GO:0015234) |
0.1 | 1.7 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.1 | 2.1 | GO:0001871 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.8 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.1 | 0.9 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 1.9 | GO:0042609 | CD4 receptor binding(GO:0042609) |
0.1 | 2.3 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 1.8 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.1 | 2.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.1 | 0.7 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 1.8 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.7 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.2 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.1 | 0.6 | GO:0050693 | LBD domain binding(GO:0050693) |
0.1 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.1 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.1 | 0.4 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.1 | 5.5 | GO:0030145 | manganese ion binding(GO:0030145) |
0.1 | 2.0 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 1.1 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.2 | GO:0005136 | interleukin-4 receptor binding(GO:0005136) |
0.1 | 0.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 2.3 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.3 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.8 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.1 | 1.0 | GO:0015288 | porin activity(GO:0015288) |
0.1 | 0.5 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.1 | 1.3 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.7 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 2.1 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.5 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 3.7 | GO:0019825 | oxygen binding(GO:0019825) |
0.1 | 6.1 | GO:0004527 | exonuclease activity(GO:0004527) |
0.1 | 0.4 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.1 | 0.3 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.8 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.6 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.9 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.1 | 0.6 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 1.6 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 1.2 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.9 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) rRNA (adenine) methyltransferase activity(GO:0016433) |
0.1 | 0.3 | GO:0047223 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity(GO:0047223) |
0.1 | 0.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.1 | 2.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.1 | 1.0 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.4 | GO:0004797 | thymidine kinase activity(GO:0004797) |
0.1 | 0.3 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 1.8 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 3.6 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.1 | 0.4 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 0.4 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 0.7 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.2 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 1.7 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 1.2 | GO:0005542 | folic acid binding(GO:0005542) |
0.1 | 2.3 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 2.3 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.1 | 3.5 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 1.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.5 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.1 | 0.1 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.1 | 2.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.3 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.2 | GO:1990698 | palmitoleoyltransferase activity(GO:1990698) |
0.1 | 0.6 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 0.2 | GO:0016936 | galactoside binding(GO:0016936) |
0.1 | 0.2 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.7 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
0.1 | 0.9 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 2.3 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.1 | 0.2 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.1 | 0.9 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.1 | 2.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.1 | 0.2 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.5 | GO:0035174 | histone serine kinase activity(GO:0035174) |
0.1 | 1.4 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.1 | 0.5 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.1 | 1.5 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 2.2 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.1 | 1.4 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.1 | 0.3 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.1 | 0.6 | GO:0004839 | ubiquitin activating enzyme activity(GO:0004839) |
0.1 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.3 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 0.3 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.2 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.1 | 1.1 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.1 | 0.4 | GO:0008301 | DNA binding, bending(GO:0008301) |
0.1 | 0.1 | GO:0000217 | DNA secondary structure binding(GO:0000217) |
0.1 | 1.4 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.1 | 0.2 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 1.6 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.1 | 0.5 | GO:0070403 | NAD+ binding(GO:0070403) |
0.1 | 0.3 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.8 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 1.0 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.1 | 0.3 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.1 | 0.1 | GO:0004878 | complement component C5a receptor activity(GO:0004878) |
0.1 | 0.2 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.2 | GO:0036328 | VEGF-C-activated receptor activity(GO:0036328) |
0.1 | 1.3 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.1 | 1.0 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.1 | 1.2 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.8 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.1 | 0.3 | GO:0035326 | enhancer binding(GO:0035326) |
0.1 | 1.9 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.3 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 2.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 1.6 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.3 | GO:0000309 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
0.0 | 3.6 | GO:0004879 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 0.6 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.0 | 4.7 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.0 | 2.7 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 1.6 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.4 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 0.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.4 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0035939 | microsatellite binding(GO:0035939) |
0.0 | 0.1 | GO:0004507 | steroid 11-beta-monooxygenase activity(GO:0004507) corticosterone 18-monooxygenase activity(GO:0047783) |
0.0 | 4.5 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.0 | 0.4 | GO:0042835 | BRE binding(GO:0042835) |
0.0 | 2.5 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 2.3 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.0 | 6.5 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 15.4 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.0 | 0.4 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 6.7 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.6 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.4 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.0 | 5.7 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.8 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 2.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.2 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.0 | 0.3 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) RNA polymerase I regulatory region sequence-specific DNA binding(GO:0001163) RNA polymerase I CORE element sequence-specific DNA binding(GO:0001164) |
0.0 | 0.1 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.0 | 0.3 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.0 | 0.7 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.0 | 1.3 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.0 | 0.1 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.0 | 0.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.0 | 0.5 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.0 | 0.5 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.0 | 1.0 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 3.3 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 1.9 | GO:0004177 | aminopeptidase activity(GO:0004177) |
0.0 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.0 | 0.8 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.0 | 4.3 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.0 | 1.5 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.0 | 0.7 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.0 | 0.2 | GO:0010348 | lithium:proton antiporter activity(GO:0010348) |
0.0 | 1.1 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.0 | 0.5 | GO:1990459 | transferrin receptor binding(GO:1990459) |
0.0 | 3.5 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.0 | 3.0 | GO:0051087 | chaperone binding(GO:0051087) |
0.0 | 0.4 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.0 | 0.3 | GO:0004935 | adrenergic receptor activity(GO:0004935) |
0.0 | 0.2 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.0 | 0.9 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.0 | 0.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.3 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.0 | 0.2 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.2 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.0 | 0.2 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
0.0 | 0.2 | GO:0004910 | interleukin-1, Type II, blocking receptor activity(GO:0004910) |
0.0 | 0.9 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.0 | 0.8 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
0.0 | 2.8 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) |
0.0 | 0.4 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 15.6 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 5.2 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 61.3 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.4 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) extracellular ATP-gated cation channel activity(GO:0004931) nucleotide receptor activity(GO:0016502) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.0 | 0.8 | GO:0015929 | hexosaminidase activity(GO:0015929) |
0.0 | 0.4 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.0 | 1.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.0 | 0.1 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.0 | 1.9 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.0 | 4.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.0 | 2.3 | GO:0001618 | virus receptor activity(GO:0001618) |
0.0 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.0 | 0.3 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.0 | 1.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.1 | GO:0052810 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.1 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
0.0 | 2.2 | GO:0009055 | electron carrier activity(GO:0009055) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.4 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.0 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
0.0 | 1.1 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.3 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.0 | 0.4 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.0 | 0.2 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.0 | 1.2 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.2 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.2 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.5 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.6 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.0 | 0.3 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.0 | 0.3 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
0.0 | 0.5 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.1 | GO:0050115 | myosin-light-chain-phosphatase activity(GO:0050115) |
0.0 | 0.2 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.0 | 0.1 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 2.9 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.0 | 0.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.1 | GO:0015039 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
0.0 | 0.2 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
0.0 | 2.7 | GO:0003823 | antigen binding(GO:0003823) |
0.0 | 1.0 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.3 | GO:0070513 | death domain binding(GO:0070513) |
0.0 | 0.1 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.0 | 0.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.0 | 0.8 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 1.9 | GO:0008168 | methyltransferase activity(GO:0008168) |
0.0 | 2.1 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.0 | 0.2 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.1 | GO:0016250 | N-sulfoglucosamine sulfohydrolase activity(GO:0016250) hydrolase activity, acting on acid sulfur-nitrogen bonds(GO:0016826) |
0.0 | 0.2 | GO:0004459 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.5 | GO:0030553 | cGMP binding(GO:0030553) |
0.0 | 0.2 | GO:0070063 | RNA polymerase binding(GO:0070063) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.2 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.0 | 0.1 | GO:0004739 | pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.0 | 0.1 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.0 | 0.2 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.2 | GO:0022850 | serotonin-gated cation channel activity(GO:0022850) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.1 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.0 | 8.2 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.0 | 0.3 | GO:0051536 | iron-sulfur cluster binding(GO:0051536) metal cluster binding(GO:0051540) |
0.0 | 0.3 | GO:0004536 | deoxyribonuclease activity(GO:0004536) |
0.0 | 0.2 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
0.0 | 0.1 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.0 | 0.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.0 | 0.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 66.2 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.4 | 8.7 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.4 | 7.5 | ST STAT3 PATHWAY | STAT3 Pathway |
0.2 | 1.0 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.2 | 0.5 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.2 | 1.1 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.2 | 0.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.2 | 5.5 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 15.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 4.6 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.9 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 5.5 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.1 | 6.6 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 8.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.1 | 4.4 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 7.4 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 7.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 8.3 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 8.4 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 7.9 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 2.7 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.1 | 3.7 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 3.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.1 | 4.7 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 3.7 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.1 | 2.1 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 3.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 3.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 9.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 6.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.1 | 0.3 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 3.4 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 2.2 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 0.5 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 4.9 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.1 | 2.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 3.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 1.9 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 1.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.8 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.1 | 1.0 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.1 | 1.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.1 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.0 | 1.8 | PID ALK1 PATHWAY | ALK1 signaling events |
0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 1.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.8 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 2.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 1.8 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 2.6 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 1.0 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 1.1 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 3.4 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 1.9 | PID LIS1 PATHWAY | Lissencephaly gene (LIS1) in neuronal migration and development |
0.0 | 1.2 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 1.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 0.8 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.8 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.0 | 0.6 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.5 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 0.9 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.0 | 0.6 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.0 | 2.6 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.2 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.6 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.5 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 1.7 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.0 | 0.7 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 0.9 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.0 | 0.2 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
0.0 | 0.4 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 6.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.0 | 1.4 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 0.1 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.0 | 0.1 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 0.1 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.1 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 16.4 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.5 | 15.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.5 | 13.1 | REACTOME INITIAL TRIGGERING OF COMPLEMENT | Genes involved in Initial triggering of complement |
0.4 | 13.7 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.4 | 8.0 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.4 | 0.4 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.4 | 7.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.3 | 4.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.3 | 0.3 | REACTOME VIF MEDIATED DEGRADATION OF APOBEC3G | Genes involved in Vif-mediated degradation of APOBEC3G |
0.3 | 6.2 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.3 | 4.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 9.0 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.3 | 52.0 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.3 | 19.5 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 3.4 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.2 | 8.9 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.2 | 0.7 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 3.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 5.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 5.3 | REACTOME RNA POL III CHAIN ELONGATION | Genes involved in RNA Polymerase III Chain Elongation |
0.2 | 8.5 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.2 | 0.6 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.2 | 13.5 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.2 | 5.4 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.2 | 2.6 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 16.4 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.2 | 7.9 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.2 | 6.7 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.5 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 5.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.2 | 0.2 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 1.6 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.2 | 17.6 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 2.7 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.2 | 7.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 1.6 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 2.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.1 | 15.1 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.1 | 2.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 7.1 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.1 | 7.5 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 5.7 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 7.1 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.1 | 2.8 | REACTOME RESOLUTION OF AP SITES VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
0.1 | 1.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 2.9 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 13.1 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 10.1 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.1 | 1.7 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 3.7 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.8 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 2.8 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 2.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 4.0 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 2.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 1.9 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 0.4 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.1 | 3.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 2.8 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.1 | 3.3 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.1 | 8.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 3.3 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 3.1 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.1 | 1.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 7.6 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.1 | 1.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 2.2 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.1 | 5.0 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.1 | 4.0 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.1 | 2.2 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 2.7 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
0.1 | 1.4 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 0.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 1.2 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.1 | 2.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.1 | 1.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.0 | REACTOME AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
0.1 | 2.4 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 0.6 | REACTOME APOBEC3G MEDIATED RESISTANCE TO HIV1 INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
0.1 | 0.1 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.1 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 4.7 | REACTOME AUTODEGRADATION OF CDH1 BY CDH1 APC C | Genes involved in Autodegradation of Cdh1 by Cdh1:APC/C |
0.1 | 1.4 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.7 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.1 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 2.6 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.4 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.7 | REACTOME TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
0.1 | 7.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.3 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.1 | 3.2 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.7 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.9 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 0.6 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 1.1 | REACTOME DNA STRAND ELONGATION | Genes involved in DNA strand elongation |
0.1 | 1.0 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 3.0 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.1 | 1.0 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.6 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.1 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.1 | 1.6 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.1 | 3.3 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.1 | 1.5 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.1 | 1.5 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 1.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 1.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.0 | 7.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.2 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 2.8 | REACTOME TRANSLATION | Genes involved in Translation |
0.0 | 1.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.8 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.4 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 1.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.1 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 1.4 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 1.5 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.2 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 1.1 | REACTOME REGULATION OF HYPOXIA INDUCIBLE FACTOR HIF BY OXYGEN | Genes involved in Regulation of Hypoxia-inducible Factor (HIF) by Oxygen |
0.0 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 1.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.5 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.0 | 0.3 | REACTOME KERATAN SULFATE KERATIN METABOLISM | Genes involved in Keratan sulfate/keratin metabolism |
0.0 | 2.0 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.6 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.7 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 3.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.0 | 0.1 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.0 | 4.4 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.0 | 1.0 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
0.0 | 0.7 | REACTOME PURINE METABOLISM | Genes involved in Purine metabolism |
0.0 | 0.6 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.5 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.0 | 0.8 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.0 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.9 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.0 | 1.3 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.8 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.2 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.3 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.0 | 0.3 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.0 | 1.7 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.3 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 0.5 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.2 | REACTOME SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the late endosome membrane |
0.0 | 0.4 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.7 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.0 | 1.5 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.0 | 0.1 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |